<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation - Khan, FA - 2013 | Cochrane Library</title> <meta content="Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation - Khan, FA - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004087.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation - Khan, FA - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004087.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004087.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation" name="citation_title"/> <meta content="Fauzia A Khan" name="citation_author"/> <meta content="Aga Khan University Hospital" name="citation_author_institution"/> <meta content="fauzia.khan@aku.edu" name="citation_author_email"/> <meta content="Hameed Ullah" name="citation_author"/> <meta content="Aga Khan University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD004087.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/07/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004087.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004087.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004087.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anesthetics, Local [therapeutic use]; Arrhythmias, Cardiac [etiology, *prevention &amp; control]; Calcium Channel Blockers [therapeutic use]; Hemodynamics [*drug effects, physiology]; Intubation, Intratracheal [*adverse effects, mortality]; Laryngoscopy [*adverse effects, mortality]; Morbidity; Myocardial Ischemia [etiology, *prevention &amp; control]; Narcotics [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004087.pub2&amp;doi=10.1002/14651858.CD004087.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="u3GUW7vS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004087\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004087\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004087.pub2",title:"Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation",firstPublishedDate:"Jul 3, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=u3GUW7vS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004087.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004087.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004087.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004087.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004087.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004087.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004087.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004087.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004087.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004087.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2333 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004087.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0024"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0025"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-sec-0111"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/appendices#CD004087-sec-0122"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/table_n/CD004087StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/table_n/CD004087StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information#CD004087-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Fauzia A Khan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information#CD004087-cr-0003">Hameed Ullah</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information/en#CD004087-sec-0134">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 July 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004087.pub2">https://doi.org/10.1002/14651858.CD004087.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004087-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004087-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004087-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004087-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004087-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004087-abs-0001" lang="en"> <section id="CD004087-sec-0001"> <h3 class="title" id="CD004087-sec-0001">Background</h3> <p>Several drugs have been used in attenuating or obliterating the response associated with laryngoscopy and tracheal intubation. These changes are of little concern in relatively healthy patients but can lead to morbidity and mortality in the high risk patient population. </p> </section> <section id="CD004087-sec-0002"> <h3 class="title" id="CD004087-sec-0002">Objectives</h3> <p>The primary objective of this review was to determine the effectiveness of pharmacological agents in preventing the morbidity and mortality resulting from the haemodynamic changes in response to laryngoscopy and tracheal intubation in adult patients aged 18 years and above who were undergoing elective surgery in the operating room setting. </p> </section> <section id="CD004087-sec-0003"> <h3 class="title" id="CD004087-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2011, Issue 6), MEDLINE (1950 to June 2011), EMBASE (1980 to June 2011), and the bibliographies of published studies. We reran our search from June 2011 to December 2012 and will deal with these studies when we update the review. </p> </section> <section id="CD004087-sec-0004"> <h3 class="title" id="CD004087-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) that compared a drug used as an intervention for preventing or attenuating the haemodynamic response to tracheal intubation to a control group, and that mentioned mortality, major morbidity, arrhythmia or electrocardiogram (ECG) evidence of ischaemia in the methodology, results, or discussion section of the reports. </p> </section> <section id="CD004087-sec-0005"> <h3 class="title" id="CD004087-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed trial quality and extracted the outcome data.</p> </section> <section id="CD004087-sec-0006"> <h3 class="title" id="CD004087-sec-0006">Main results</h3> <p>We included 72 RCTs. The included trials studied the effects of 32 drugs belonging to different pharmacological groups. Only two trials mentioned the primary outcome of morbidity and mortality related to the haemodynamic response to tracheal intubation. Of the secondary outcomes, 40 of the included trials observed arrhythmia only, 11 observed myocardial ischaemia only and 20 observed both arrhythmias and myocardial ischaemia. Arrhythmias were observed in 2932 participants and myocardial ischaemia in 1616 participants. Arrhythmias were observed in 134 out of 993 patients in the control group compared to 80 out of 1939 in the intervention group. The risk of arrhythmias was significantly reduced with pharmacological interventions in the pooled data (Peto odds ratio (OR) 0.19, 95% CI 0.14 to 0.26, P &lt; 0.00001, I<sup>2</sup>= 47%). Local anaesthetics, calcium channel blockers, beta blockers and narcotics reduced the risk of arrhythmia in the intervention group compared to the control group. Myocardial ischaemia was observed in 21 out of 604 patients in the control group compared to 10 out of 1012 in the treatment group; the result was statistically significant (Peto OR 0.45, 95% CI 0.22 to 0.92, P = 0.03, I<sup>2</sup> = 19%). However, in subgroup analysis only local anaesthetics significantly reduced the ECG changes indicating ischaemia, but this evidence came from one study. The majority of the studies had a negative outcome. Hypotension and bradycardia were reported with 40 µg kg<sup>‐1</sup> intravenous alfentanil, chest rigidity with 75 ug kg<sup>‐1</sup> alfentanil, and increased bronchomotor tone with sympathetic blockers. </p> <p>There were 17 studies which included high risk patients. Pharmacological treatment in this group resulted in the reduction of arrhythmias when the data from nine trials looking at arrhythmias were pooled (Peto OR 0.18, 95% CI 0.05 to 0.59, P = 0.005, I<sup>2</sup> = 80%). The analysis from four studies was not included. Three of these trials looked at the effect of sympathetic blockers but arrhythmias or myocardial ischaemia was observed throughout the perioperative period in two studies and some patients had arrhythmias due to atropine premedication in the third study. In the fourth study the authors mentioned myocardial ischaemia in the objectives section but did not report it in the results. </p> </section> <section id="CD004087-sec-0007"> <h3 class="title" id="CD004087-sec-0007">Authors' conclusions</h3> <p>The risk of arrhythmias associated with tracheal intubation was significantly reduced with pre‐induction administration of local anaesthetics, calcium channel blockers, beta blockers and narcotics compared to placebo. Pharmacological intervention also reduced the risk of ECG evidence of myocardial ischaemia in the pooled data. Lignocaine pretreatment showed a significant effect but evidence came from one study only. The data suggested that there may be a reduction in ECG evidence of myocardial ischaemia with beta blocker pretreatment but this difference was not statistically significant. There is a need to focus on outcomes rather than haemodynamic measurements alone when studying this response in future trials. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004087-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004087-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004087-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004087-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004087-abs-0005">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004087-abs-0004" lang="en"> <h3>Drugs for preventing major morbidity and mortality related to blood pressure and heart rate changes associated with tracheal intubation </h3> <p>During general anaesthesia, a tube may be inserted into the trachea (windpipe) using an instrument called a laryngoscope in order to safely deliver oxygen and anaesthetic gases and to remove carbon dioxide. This procedure is known as laryngoscopy and tracheal intubation. It initiates a reflex response (the haemodynamic response to intubation) of an increase in blood pressure and heart rate. Several drugs in varied doses and by different routes have been used to blunt or prevent this response in order to prevent serious complications for the heart and the brain, which may even be fatal. This is because the increase in blood pressure and heart rate may put undue stress on the heart and the brain circulation. In some patients it may lead to abnormal heart rhythm (arrhythmias) and lack of oxygen to the heart muscle (myocardial ischaemia) resulting in changes in recorded electrical activity of the heart (shown on the electrocardiogram (ECG)), heart failure, or stroke. In spite of several studies on the use of drugs to suppress this response, it remains unclear what the best drugs to use are and in what dosages. </p> <p>We included adult patients aged 18 years and above undergoing elective surgery in the operating room setting. We found that the effects of drugs on the stress response was the subject of 72 studies. The investigators used 32 drugs. Promising results were seen in the reduction of arrhythmias with intravenous injections of beta blockers (drugs that decrease the heart rate), narcotics (drug used to treat pain), local anaesthetics, and calcium channel blockers (drugs that block movement of calcium). Serious side effects were only reported with high doses of narcotics and an increase in airway pressure was seen in some patients with beta blockers. Only local anaesthetic drugs clearly reduced the risk of myocardial ischaemia but this evidence came from only one trial. </p> <p>There was some difficulty in comparing and interpreting the results of these different trials. Patients at a high risk of complications were investigated in 17 trials. A reduction in arrhythmias with treatment was seen in this high risk group but the number of studies was too small to reach a conclusion. Doctors need to further research the effects of drugs used for blunting the haemodynamic response and their effect on outcomes in terms of morbidity, in a standardized manner. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004087-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004087-sec-0117"></div> <h3 class="title" id="CD004087-sec-0118">Implications for practice</h3> <section id="CD004087-sec-0118"> <p>This review suggests that pre‐induction or co‐induction administration of local anaesthetics, calcium channel blockers, beta blockers, or narcotics are effective in reducing the risk of arrhythmias associated with laryngoscopy and tracheal intubation. There is no evidence that these agents influence morbidity or mortality in this setting. The evidence does not allow us to determine a recommended dose or route of administration for these agents. </p> <p>The results of a single study (<a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>) suggest that the administration of lignocaine in this setting also reduces the risk of ECG changes suggestive of myocardial ischaemia. Overall, these studies have a low power to detect a reduction in the risk of such changes and we are unable to confirm any benefit from the use of other agents for this purpose. </p> </section> <h3 class="title" id="CD004087-sec-0119">Implications for research</h3> <section id="CD004087-sec-0119"> <p>There is a deficiency of literature that has looked at morbidity related to the haemodynamic response to laryngoscopy and tracheal intubation and there is need to focus on this aspect in future research. Researchers looking at the blood pressure and heart rate responses should report the consequences of these short lived changes and refer to them as part of their methodology rather than a chance comment in the results. They should also look at short term immediate effects as well as any postoperative effects of these changes. The identified trials were heterogeneous in terms of drug dosages, routes of administration, and timing of intervention of the same drug as well as different study drugs and the anaesthetic drugs used for induction. These need to be standardized to allow pooling of data. </p> <p>Most literature on the haemodynamic response to tracheal intubation has focused on healthy ASA 1 and 2 patients. In view of the difficulty in undertaking placebo controlled trials in the high risk population, a combination of smaller doses of effective drugs can be compared with doses of single drugs that were found effective in isolated studies. </p> <p>Randomized controlled trials may not be a good study design to assess the rate of complications for interventions like tracheal intubation. One approach may be to establish prospective registries or a multi‐database for a large cohort. Recently a similar approach was taken for looking at complications related to paediatric regional blocks, where a consortium of 14 North American hospitals established the Paediatric Regional Anaesthesia Network (PRAN) to study paediatric epidural data. They recently published their report on the first three years of data (<a href="./references#CD004087-bbs2-0111" title="PolanerDM , TaenzerAH , WalkerBJ , BosenbergA , KraneEJ , SureshS , et al. Pediatric Regional Anesthesia Network (PRAN): A multi‐institutional study of the use and incidence of complicatiopns of pediatric regional anesthesia. Anesthesia and Analgesia2012;115:1353‐64. [PUBMED: 22696610] ">Polaner 2012</a>). Another design approach could be a large scale survey, or well designed national or regional audits. An example of such a survey is NAP 3 in the UK, which was undertaken to study the major complications of central neuraxial blocks (<a href="./references#CD004087-bbs2-0102" title="CookTM , CounsellD , WildsmithJA . Major complications of central neuraxial block: Report of the Third National Audit Project of the Royal College of Anaesthetists. British Journal of Anaesthesia2009;102:179‐90. [PUBMED: 19139027] ">Cook 2009</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004087-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004087-sec-0022"></div> <div class="table" id="CD004087-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pharmacological agents compared with placebo or no treatment for attenuating the haemodynamic response to tracheal intubation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Adult patients 18 years and above undergoing elective surgery</b> </p> <p><b>Settings: Operating room</b> </p> <p><b>Intervention: Pharmacological agents given for the specific purpose of attenuating the haemodynamic response to tracheal intubation</b> </p> <p><b>Comparison: Control group receiving placebo or no treatment</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Pharmacological agents</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Arrhythmias ‐ by drug type in all patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.19</b> </p> <p>(<b>0.14 to 0.27</b>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>2902</b> <br/> <b>(57)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>·  .</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> <br/> <b>(21 to 40)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Arrhythmias ‐ high risk patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.18</b> </p> <p><b>(0.05 to 0.59)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>337</b> <br/> <b>(9)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>· </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> <b>(4 to 49)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Myocardial Ischaemia ‐ by drug type in all patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>0.36</b> </p> <p><b>(0.16 to 0.8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>1636</b> <br/> <b>(30)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>· </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>13 per 1000</b> </p> <p><b>(6 to 28)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial Ischaemia ‐ high risk patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.67</b> </p> <p><b>(0.27 to 1.67)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>395</b> <br/> <b>(12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>·  </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 1000</b> </p> <p><b>(22 to 123)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; [other abbreviations, e.g.. OR, etc] </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>43 of the studies were blinded.All studies mentioned randomization but details were only provided by eight; 13 studies described allocation concealment </p> <p><sup>2</sup>Six studies out of nine with high risk patients were blinded </p> <p><sup>3</sup>Eight studies were blinded.In nine studies details of randomization were mentioned; 12 had allocation concealment and five studies had withdrawals </p> <p><sup>4</sup>Six studies out of 12 with high risk patients were blinded </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004087-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004087-sec-0023"></div> <p>Both laryngoscopy and tracheal intubation are associated with a sympathetically mediated increases in blood pressure and heart rate, which may be deleterious in patients with underlying cardiovascular and cerebrovascular diseases (<a href="./references#CD004087-bbs2-0114" title="ShribmanAJ , SmithG , AcholaKJ . Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. British Journal of Anaesthesia1987;59:295‐9. [PUBMED: 3828177] ">Shribman 1987</a>). These changes are of little consequence in healthy patients (<a href="./references#CD004087-bbs2-0109" title="KovacLA . Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. Journal of Clinical Anaesthesia1996;8:63‐79. [PUBMED: 8695083] ">Kovac 1996</a>) but have lead to myocardial ischaemia (reduced blood supply to the muscles of the heart) (<a href="./references#CD004087-bbs2-0103" title="EdwardsND , AlfordAM , DobsonPM . Myocardial ischaemia during tracheal intubation and extubation. British Journal of Anaesthesia1994;73:537‐9. [PUBMED: 7999498] ">Edwards 1994</a>), malignant ventricular arrhythmias (abnormal rhythm), cardiac failure (<a href="./references#CD004087-bbs2-0105" title="FoxE , SklarG , HillC , VillanuevaR , KingB . Complications related to the pressor response to endotracheal intubation. Anesthesiology1977;47:524‐5. [PUBMED: 337858] ">Fox 1977</a>), intracranial haemorrhage and raised intracranial pressure (<a href="./references#CD004087-bbs2-0112" title="RobinsonR , ClancyM . In patients with head injury undergoing rapid sequence intubation, does pretreatment with IV lignocaine / lidocaine lead to improve neurological outcome? A review of literature. Emergency Medicine Journal2001;18:453‐7. ">Robinson 2001</a>) in vulnerable patients. </p> <p>Several drugs belonging to different pharmacological classes have been used in either attenuating or obliterating this response. These include narcotics (<a href="./references#CD004087-bbs2-0012" title="CrawfordDC , FellD , AcholaKJ , SmithG . Effects of alfentanil on the pressor and catecholamine responses to tracheal intubation. British Journal of Anaesthesia1987;59:707‐12. [PUBMED: 3111508] ">Crawford 1987</a>; <a href="./references#CD004087-bbs2-0108" title="KayB , HealyTE , BolderPM . Blocking the circulatory responses to tracheal intubation. A comparison of fentanyl and nalbuphine. Anaesthesia1985;40:960‐3. [PUBMED: 4061801] ">Kay 1985</a>; <a href="./references#CD004087-bbs2-0110" title="McAtamneyD , O'HareR , HughesD , CarabineU , MirakhurR . Evaluation of remifentanil for control of haemodynamic response to tracheal intubation. Anaesthesia1998;53:1223‐7. [PUBMED: 10193231] ">McAtamney 1998</a>), local anaesthetics (<a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>), calcium channel blockers (<a href="./references#CD004087-bbs2-0006" title="AtleeJL , DhameeMS , OlundTL , GeorgeV . The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:280‐5. [PUBMED: 10648307] ">Atlee 2000</a>) and other peripheral vasodilators, sympathetic blockers (<a href="./references#CD004087-bbs2-0061" title="SharmaS , GhaniAA , WinN , AhmadM . Comparison of two bolus doses of esmolol for attenuation of haemodynamic response to tracheal intubation. Medical Journal of Malaysia1995;50:372‐6. [PUBMED: 8668059] ">Sharma 1995</a>), and centrally acting adrenergic agonists (<a href="./references#CD004087-bbs2-0113" title="ScheininB , LindgrenL , RandellT , ScheininH , ScheininM . Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. British Journal of Anaesthesia1992;68:126‐31. [PUBMED: 1347229] ">Scheinin 1992</a>). Each class has undesirable side effects. The majority of studies do not provide any information regarding outcome in terms of morbidity. Few studies have evaluated the risk of ischaemia and arrhythmias induced by laryngoscopy and intubation (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>; <a href="./references#CD004087-bbs2-0072" title="ZargarJA , NaqashIA , GurcooSA . Comparative evaluation of the effect of metoprolol and esmolol on rate pressure product and ECG changes during laryngoscopy and endotracheal intubation in controlled hypertensives patients. Indian Journal of Anaesthesia2002;46:365‐8. ">Zargar 2002</a>), but no clear cause effect relationship has been established. It still needs to be shown that suppression of this response is of benefit to the patients in terms of outcome. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004087-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004087-sec-0024"></div> <p>The primary objective of this review was to determine the effectiveness of pharmacological agents in preventing the morbidity and mortality resulting from the haemodynamic changes in response to laryngoscopy and tracheal intubation in adult patients aged 18 years and above who were undergoing elective surgery in the operating room setting. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004087-sec-0025" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004087-sec-0025"></div> <section id="CD004087-sec-0026"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004087-sec-0027"> <h4 class="title">Types of studies</h4> <p>We included prospective randomized controlled trials (RCTs) which studied the effect of different pharmacological agents on the haemodynamic response to laryngoscopy and tracheal intubation in the presence of a control group. We included both blinded and unblinded trials. </p> </section> <section id="CD004087-sec-0028"> <h4 class="title">Types of participants</h4> <p>We included trials involving adult patients aged 18 years and above, of any race and of either sex, undergoing elective surgery in the operating room setting. We excluded trials of patients undergoing tracheal intubation at other sites such as the intensive care unit (ICU) and accident and emergency departments. </p> </section> <section id="CD004087-sec-0029"> <h4 class="title">Types of interventions</h4> <p>We included any pharmacological agent given for the specific purpose of attenuating the tracheal intubation associated haemodynamic response. We excluded studies relating to anaesthetic agents which form part of routine anaesthesia for example sedatives, induction agents, inhalational anaesthetics, and muscle relaxants. We grouped the drugs as follows: local anaesthetics; calcium channel blockers; sympathetic blockers (beta blockers, alpha blockers, alpha and beta blockers, and ganglion blockers); peripheral vasodilators; centrally acting adrenergic agonists; angiotensin converting enzyme (ACE) inhibitors; narcotics; and a miscellaneous group. </p> <p>We included drugs given by different routes that is oral, sublingual, intravenous, tracheal, topical, inhalational. The intravenous route included drugs given by either bolus injection or infusion. </p> <p>We attempted to answer the following questions.</p> <p> <ol id="CD004087-list-0001"> <li> <p>Does the administration of either narcotics, local anaesthetics, calcium channel blockers and other peripheral vasodilators, sympathetic blockers, centrally acting adrenergic agonists, and other miscellaneous drugs result in a significant reduction in cardiac, neurological, any other morbidity, or mortality associated with laryngoscopy and tracheal intubation when compared with placebo? </p> </li> <li> <p>Is the administration of any of the above pharmacological agent more effective than the placebo in respect to question 1? </p> </li> <li> <p>Is the route of administration of the above agents associated with significant differences in respect of the outcomes in question 1? </p> </li> <li> <p>Is the administration of above agents associated with adverse haemodynamic respiratory or other unwanted effects? </p> </li> </ol> </p> </section> <section id="CD004087-sec-0030"> <h4 class="title">Types of outcome measures</h4> <p>We included RCTs which mentioned the following outcomes (either primary or secondary) in the methodology, results, or discussion sections. </p> <section id="CD004087-sec-0031"> <h5 class="title">Primary outcomes</h5> <p>We considered as the primary outcome major morbidity or mortality related to haemodynamic changes which may follow tracheal intubation. As the majority of these changes settled within five to 15 minutes, only morbidity and mortality occurring during this period or as a direct consequence of these changes were included. </p> <p>Examples of major morbidity were as follows.</p> <p> <ol id="CD004087-list-0002"> <li> <p>Electrocardiographic (ECG) evidence of intraoperative ischaemia following intubation subsequently leading to myocardial infarction (evidence of raised creatinine phosphokinase MB fraction or troponin). </p> </li> <li> <p>Rupture of an aneurysm.</p> </li> <li> <p>Acute cerebral haemorrhage.</p> </li> <li> <p>Sudden deterioration in cardiovascular status or neurological status related to the haemodynamic response leading to prolongation of operating room or recovery room stay or admission to a critical care area. </p> </li> </ol> </p> <p>We collected the data as number of patients who had mortality or morbidity.</p> </section> <section id="CD004087-sec-0032"> <h5 class="title">Secondary outcomes</h5> <p>We considered the following as secondary outcomes.</p> <p> <ol id="CD004087-list-0003"> <li> <p>Arrhythmias: studies recording any cardiac arrhythmia during or following intubation were included. We collected the data as the number of patients who had arrhythmias during the above period. </p> </li> <li> <p>Studies observing ECG evidence of ischaemia. We collected the data as the number of patients who had ECG evidence of ischaemia, ST segment depression on the ECG during or as a consequence of tracheal intubation. </p> </li> </ol> </p> </section> </section> </section> <section id="CD004087-sec-0033"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004087-sec-0034"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2011, Issue 6), MEDLINE (1950 to June 2011), and EMBASE (1980 to June 2011) using the search strategies listed in the appendices (<a href="./appendices#CD004087-sec-0123">Appendix 1</a> (CENTRAL); <a href="./appendices#CD004087-sec-0124">Appendix 2</a> (MEDLINE); <a href="./appendices#CD004087-sec-0125">Appendix 3</a> (EMBASE)). </p> <p>We reran the searches in December 2012 to identify papers published in 2011 to 2012 and the additional studies identified in this second search are listed in the <a href="./references#CD004087-sec-0141" title="">Characteristics of studies awaiting classification</a>. We will deal with these studies when we update our review. </p> <p>Both authors independently searched the literature. We did not impose any language restriction. We did not seek unpublished studies. </p> </section> <section id="CD004087-sec-0035"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of the RCTs for additional studies.</p> </section> </section> <section id="CD004087-sec-0036"> <h3 class="title" id="CD004087-sec-0036">Data collection and analysis</h3> <section id="CD004087-sec-0037"> <h4 class="title">Selection of studies</h4> <p>We (FK, HU) independently reviewed the titles and the abstracts of the studies and reached a consensus on the abstracts that met the inclusion criteria. In the case of a disagreement regarding the inclusion of an abstract, we obtained the full article. We independently reviewed the full texts of all identified abstracts. We resolved any disagreements through discussion. As no major conflict arose we did not require a third review author. We were not blinded to the names of the authors, the institution, or the journal of publication. </p> <p>We included RCTs on adult patients undergoing elective surgery, of either sex and any race, aged 18 years and above, who received a pharmacological intervention before or at induction of anaesthesia to prevent the haemodynamic response related to laryngoscopy and tracheal intubation. </p> <p>We excluded RCTs involving patients in whom tracheal intubation was performed in other settings, for example the intensive care unit (ICU) or accident and emergency unit, or were undergoing emergency surgery. We also excluded trials without control groups. We excluded studies of tracheal intubation without the use of muscle relaxants or which involved the administration of induction agent with a target controlled infusion pump. We also excluded studies that simply mentioned looking for an 'abnormality in ECG' or 'changes in ECG'. This is because these authors did not differentiate between arrhythmias and the ECG changes of ischaemia. </p> <p>We also tried contacting some of the study authors for clarification (<a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a>; <a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>) but to date we have not received a reply. We did not contact authors for unpublished data. </p> </section> <section id="CD004087-sec-0038"> <h4 class="title">Data extraction and management</h4> <p>We (FK, HU) completed a data extraction form for each study reviewed (<a href="./appendices#CD004087-sec-0126">Appendix 4</a>). We recorded the following information: the type and number of patients; pharmacological intervention (route, dose, and timing); outcome (primary and secondary, duration of observation, and any adverse effects of the given drug). </p> <p>One author (HU) entered the data for the meta‐analysis into Revman 5.1, which were then checked by the second author (FK). </p> </section> <section id="CD004087-sec-0039"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We (FK, HU) independently evaluated the validity and design characteristics of each selected study. This included: random sequence generation; allocation concealment; blinding of participants and personnel; blinding of outcome assessment; incomplete outcome data; and selective reporting, as recommended in the Cochrane Collaboration's recommended tool for assessing risk of bias (<a href="./references#CD004087-bbs2-0106" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: HigginsJPT , GreenS (editors) editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>). </p> <p>We classified each trial quality component as: 'low risk of bias', 'high risk of bias', or 'unclear risk of bias'. We assessed attrition bias as low if the number of participants recruited in the trial was the same as the number of participants in whom the results were reported, or if an intention‐to‐treat (ITT) analysis had been performed after attrition. We assessed selective reporting as at low risk of bias if the expected outcome was pre‐specified in the methodology section of the study. We resolved disagreements by discussion. </p> <p>We completed a risk of bias summary table for each study.</p> </section> <section id="CD004087-sec-0040"> <h4 class="title">Measures of treatment effect</h4> <p>Our outcome data were dichotomous. We used Peto odds ratios (OR) to establish the statistical difference between the intervention and control groups. We interpreted an OR of less than one as showing that the experimental intervention decreased the occurrence of an adverse outcome. </p> </section> <section id="CD004087-sec-0041"> <h4 class="title">Unit of analysis issues</h4> <p>For any trials using cluster randomization or enrolling more than two arms we used the methods prescribed by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004087-bbs2-0106" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: HigginsJPT , GreenS (editors) editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>) and identified and included data from only the intervention groups relevant to our systematic review. Detailed descriptions of only the groups relevant to our review are mentioned in the table <a href="./references#CD004087-sec-0140" title="">Characteristics of included studies</a>. We have mentioned any groups that were not included in our systematic review in the notes section of each study. </p> </section> <section id="CD004087-sec-0042"> <h4 class="title">Dealing with missing data</h4> <p>Intention‐to‐treat analysis (ITT) analysis is recommended in order to minimize bias. No consensus exists on how to handle missing data in an ITT analysis in systematic reviews (<a href="./references#CD004087-bbs2-0106" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: HigginsJPT , GreenS (editors) editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>). We excluded all participants from the analysis where the outcomes were missing. </p> </section> <section id="CD004087-sec-0043"> <h4 class="title">Assessment of heterogeneity</h4> <p>Our review was designed to include studies with several different pharmacological interventions for reducing morbidity associated with the haemodynamic response to tracheal intubation. We had specified in the protocol (<a href="./references#CD004087-bbs2-0115" title="KhanFA , UllahH . Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database of Systematic Reviews2003, Issue 1. [DOI: 10.1002/14651858.CD004087] ">Khan 2003</a>) that we would combine the results from trials of similar pharmacological class of drugs. For assessing heterogeneity amongst the trials of each pharmacological class, by using the I<sup>2</sup> statistic, we referred to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004087-bbs2-0106" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: HigginsJPT , GreenS (editors) editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane‐handbook.org, 2011. ">Higgins 2011)</a>. We found an overlap between the classes. We therefore modified the given scale as follows: </p> <p> <ul id="CD004087-list-0004"> <li> <p>0% to 30% not important;</p> </li> </ul> <ul id="CD004087-list-0005"> <li> <p>31% to 60% moderate heterogeneity;</p> </li> </ul> <ul id="CD004087-list-0006"> <li> <p>61% to 80% substantial heterogeneity;</p> </li> </ul> <ul id="CD004087-list-0007"> <li> <p>81 % to 100% considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD004087-sec-0044"> <h4 class="title">Assessment of reporting biases</h4> <p>We looked at the outcomes listed in the methods section of the trials and compared them with the outcomes reported in the results section. When the outcome was not mentioned in the methods but only reported in the results we listed it as at high risk of reporting bias. </p> </section> <section id="CD004087-sec-0045"> <h4 class="title">Data synthesis</h4> <p>We pooled the data from various trials, where appropriate, using Review Manager 5.1. We chose a fixed‐effect model. The outcomes were rare events, therefore we used Peto's OR to estimate the effect size. We expressed the treatment effect as a pooled OR with 95% confidence interval (CI). We plotted the results of each study as point estimates with corresponding 95% CIs. We did not generate plots where only a single study was available for an intervention; these are mentioned in the text description and tallied in <a href="./appendices#CD004087-sec-0127">Appendix 5</a>. </p> </section> <section id="CD004087-sec-0046"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses.</p> <p> <ol id="CD004087-list-0008"> <li> <p>Based on the pharmacological class of drugs that were used for suppressing the haemodynamic response related to tracheal intubation. These groups were: local anaesthetics, calcium channel blockers, sympathetic blockers, peripheral vasodilators, centrally acting alpha agonists, ACE inhibitors, narcotics, and a miscellaneous drugs group. </p> </li> <li> <p>Based on trials using the same drug within a single pharmacological group.</p> </li> <li> <p>Based on enrolment into the trials of high risk patients who were likely to have a higher risk of outcome events versus low risk patients. </p> </li> </ol> </p> <p>For trials dealing with more than one pharmacological group, we broke them into the review intervention groups (one study group receiving one drug = one intervention). We then combined data from these individual intervention groups with the other studies of the same experimental pharmacological group to make a single group for subgroup analysis. </p> <p>We assessed heterogeneity among trials by looking at the I<sup>2</sup> statistic for heterogeneity. Where this figure was greater than 60%, it indicated substantial or considerable heterogeneity. </p> </section> <section id="CD004087-sec-0047"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the variability in the patient population, drug doses, and time points of measurements, sensitivity analysis was not applicable to this review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004087-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004087-sec-0048"></div> <section id="CD004087-sec-0049"> <h3 class="title">Description of studies</h3> <section id="CD004087-sec-0050"> <h4 class="title">Results of the search</h4> <p>(See <a href="#CD004087-fig-0001">Figure 1</a>) </p> <div class="figure" id="CD004087-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD004087-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> <p>Our initial search (up to June 2011) identified 3854 citations across all sources, of which 290 were duplicate citations and 3188 were not relevant randomized trials. We were unable to obtain abstracts for 14 titles and full papers for an additional six titles identified in our initial search. These papers have been included in our <a href="./references#CD004087-sec-0141" title="">Characteristics of studies awaiting classification</a>. </p> <p>We reran our search in 2012. A further seven studies were identified. These papers have also been placed in the <a href="./references#CD004087-sec-0141" title="">Characteristics of studies awaiting classification</a> and will be dealt with in our next update. </p> <p>One publication (<a href="./references#CD004087-bbs2-0081" title="FujiiY , TanakaH , SaitohY , ToyookaH . Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Canadian Journal of Anaesthesia1995;42:785‐8. [PUBMED: 7497558] ">Fujii 1995</a>) was initially selected but has now been removed to the <a href="./references#CD004087-bbs1-0002" title="">Studies awaiting classification</a> as the author is being investigated by his institution. We retrieved the full text of 376 trials. We excluded 275 trials because our primary or secondary outcomes were not mentioned in either the methodology, results, or discussion sections (Characteristics of excluded studies). One publication was a duplicate publication of <a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a> (see <a href="#CD004087-sec-0056">Included studies</a>) . We included 72 studies in the review. </p> <section id="CD004087-sec-0051"> <h5 class="title">Control</h5> <p>The total numbers of patients in the control group for arrhythmias was 993, and the total number for ECG evidence of myocardial ischaemia was 604. The control group in all but four studies received a placebo (normal saline). In the four studies (<a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0034" title="LindgrenL , SarnivaraL , KlemolaUM . Protection by fentanyl against cardiac dysrhythmias during induction of anaesthesia. European Journal of Anaesthesiology1987;4:229‐33. [PUBMED: 3653018] ">Lindgren 1987</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>) no drug was administered in the control group. </p> </section> <section id="CD004087-sec-0052"> <h5 class="title">Interventions</h5> <p>There were 1939 patients in the intervention group of studies looking at arrhythmias.</p> <p>There were 1012 patients in the intervention group studying ECG changes of myocardial ischaemia. </p> <p>Of the included studies, 54 assessed a single drug, 15 assessed two different drugs, and three studies assessed three different drugs. </p> </section> <section id="CD004087-sec-0053"> <h5 class="title">Route of administration</h5> <p>The intravenous route (IV) was used in 49 studies, the oral route in 13. Of the remaining 10 studies, two used the sublingual route (calcium channel blockers), one used the transdermal route (nitroglycerine), five administered local anaesthetics either by inhalation or transtracheally, and two used both the oral and IV route in different arms of the same study. </p> </section> <section id="CD004087-sec-0054"> <h5 class="title">Type of patients</h5> <p>In 50 studies, the patients investigated were American Society of Anesthesiologists classification of anaesthesia risk (ASA) 1 and 2 only. Apart from the high risk studies, four studies additionally included ASA 3 and ASA 4 patients in addition to ASA 1 and 2 patients (<a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>). Further details on status were only available from one study (<a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>), where these patients had several additional risk factors for example ischaemic heart disease, diabetes, obesity, etc. In one study the ASA status of the patients was not mentioned (<a href="./references#CD004087-bbs2-0046" title="MikawaK , MaekawaN , HasegawaM , KaetsuH , GotoR Hideaki Y , et al. Effects of Nilvadipine on the cardiovascular responses to tracheal intubation. Journal of Clinical Anaesthesia1992;4:292‐6. [PUBMED: 1358132] ">Mikawa 1992a</a>). </p> <p>We identified 17 studies that investigated only high risk patients. Data from two studies were not included (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>). The number of patients enrolled in the studies looking at arrhythmias was 337 in the high risk studies in comparison with 28,36l enrolled in the lower risk studies. There were 395 patients enrolled in the high risk studies that looked at myocardial ischaemia compared to 1306 in the lower risk studies. </p> </section> <section id="CD004087-sec-0055"> <h5 class="title">Follow‐up</h5> <p>The period of follow‐up varied from three minutes post‐intubation (<a href="./references#CD004087-bbs2-0045" title="MikawaK , MaekawaN , KaetsuH , GotoR , YakuH , OboraH . Effects of adenosine triphosphate on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1991;67:410‐5. [PUBMED: 1931397] ">Mikawa 1991b</a>) to 20 minutes following the study drug (<a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>). </p> </section> </section> <section id="CD004087-sec-0056"> <h4 class="title">Included studies</h4> <p>We included 72 publications with an adult population aged above 18 years. The sample size varied from 12 (<a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>) to 548 participants (<a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>). Nine studies investigated local anaesthetics, 10 studies calcium channel blockers, 19 studies sympathetic blockers, 10 studies narcotics, five studies peripheral vasodilators, two studies centrally acting alpha agonists, and six studies miscellaneous drugs. The remaining 11 studies investigated drugs belonging to more than one pharmacological class in the same trial. For more details see <a href="./references#CD004087-sec-0140" title="">Characteristics of included studies</a>. </p> </section> <section id="CD004087-sec-0057"> <h4 class="title">Excluded studies</h4> <p>No study was excluded.</p> <section id="CD004087-sec-0058"> <h5 class="title"><i>Studies awaiting classification</i> </h5> <p>One study (<a href="./references#CD004087-bbs2-0081" title="FujiiY , TanakaH , SaitohY , ToyookaH . Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Canadian Journal of Anaesthesia1995;42:785‐8. [PUBMED: 7497558] ">Fujii 1995</a>) with hypertensive patients was available but the lead author is being investigated by his institution for intellectual dishonesty (see <a href="./references#CD004087-sec-0141" title="">Characteristics of studies awaiting classification</a>). </p> <p>There were 20 additional titles identified in our initial search which may be relevant. Abstracts were available for only six studies and titles only for the remaining 14. Full texts of these publications were not available through our library, inter‐library loans, or through the Cochrane Anaesthesia Review Group (CARG). Of these 20 studies, 17 are from non‐English journals (see <a href="./references#CD004087-sec-0141" title="">Characteristics of studies awaiting classification</a>). </p> <p>We reran our search from 2011 to 2012. Seven studies identified in our search rerun have also been added to this section. We will deal with them when we update the review. </p> </section> </section> </section> <section id="CD004087-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>We evaluated the overall quality of the trials based on the domains described in the following subsections. The various bias domains are presented in the <a href="#CD004087-sec-0059">Risk of bias in included studies</a> (see <a href="#CD004087-fig-0002">Figure 2</a>; <a href="#CD004087-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD004087-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004087-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004087-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004087-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD004087-sec-0060"> <h4 class="title">Random sequence generation</h4> <p>All included studies were randomized and mentioned randomization in the methodology, but the actual method used for randomization was stated by only 10 trials (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0041" title="MemisD , TuranA , KaramanlioqluB , SekerS , TüreM . Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesia2006;23:686‐90. [PUBMED: 16805934] ">Memis 2006</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0064" title="SongD , SinghH , WhitePF , GadhialiM , GriffinJD , KleinKW . Optimal dose of Nicardipine for maintenance of hemodynamic stability after tracheal intubation and skin incision. Anesthesia and Analgesia1997;85:1247‐51. [PUBMED: 9390588] ">Song 1997</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>; <a href="./references#CD004087-bbs2-0069" title="VictoryRA , GajrajNM , PaceNA , OstmanLP . Nebulized bupivacaine attenuates the heart rate responses following tracheal intubation. Journal of Clinical Anaesthesia1995;7:9‐13. [PUBMED: 7772369] ">Victory 1995</a>). </p> </section> <section id="CD004087-sec-0061"> <h4 class="title">Allocation</h4> <p>In 63 studies, the authors did not state the method of concealment of allocation (whether the investigators were unable to predict the prospective group to which a participant would be allocated). We categorized these studies as 'unclear'. Concealment was adequate in nine studies (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0027" title="KayaFN , YavascaogluB , BaykaraM , AltunGT , GülhanN , AtaF . Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. Acta Anaesthesiologica Scandinavica2008;52:1076‐80. [PUBMED: 18840107] ">Kaya 2008</a>; <a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0041" title="MemisD , TuranA , KaramanlioqluB , SekerS , TüreM . Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesia2006;23:686‐90. [PUBMED: 16805934] ">Memis 2006</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0054" title="OxornD , KnoxJW , HillJ . Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesia1990;37:206‐9. [PUBMED: 1968784] ">Oxorn 1990</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>). </p> </section> <section id="CD004087-sec-0062"> <h4 class="title">Blinding</h4> <p>Both participants and outcome assessors were blinded in 53 studies; 16 studies were not blinded. Three studies (<a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0054" title="OxornD , KnoxJW , HillJ . Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesia1990;37:206‐9. [PUBMED: 1968784] ">Oxorn 1990</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) used subject experts (cardiologists) for analysis of the ECG changes. </p> </section> <section id="CD004087-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>Withdrawals were specifically mentioned in seven trials (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>; <a href="./references#CD004087-bbs2-0064" title="SongD , SinghH , WhitePF , GadhialiM , GriffinJD , KleinKW . Optimal dose of Nicardipine for maintenance of hemodynamic stability after tracheal intubation and skin incision. Anesthesia and Analgesia1997;85:1247‐51. [PUBMED: 9390588] ">Song 1997</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). In the rest of the studies, the number of participants entering the trials and the number subjected to analysis, as mentioned in the results, were the same. Two studies (<a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>; <a href="./references#CD004087-bbs2-0064" title="SongD , SinghH , WhitePF , GadhialiM , GriffinJD , KleinKW . Optimal dose of Nicardipine for maintenance of hemodynamic stability after tracheal intubation and skin incision. Anesthesia and Analgesia1997;85:1247‐51. [PUBMED: 9390588] ">Song 1997</a>) reported six withdrawals each and one study (<a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>) reported 10 withdrawals. Two studies (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>) reported 12 dropouts but no ITT analysis was performed. <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a> reported four patients who did not complete the study and ITT analysis was performed. The reasons for withdrawal were protocol violation in one study (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>); difficulty in tracheal intubation in four studies (<a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0064" title="SongD , SinghH , WhitePF , GadhialiM , GriffinJD , KleinKW . Optimal dose of Nicardipine for maintenance of hemodynamic stability after tracheal intubation and skin incision. Anesthesia and Analgesia1997;85:1247‐51. [PUBMED: 9390588] ">Song 1997</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>); the use of active pharmacological intervention to keep blood pressure stable in two studies (<a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>); and refusal to participate in one study (<a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>). </p> </section> <section id="CD004087-sec-0064"> <h4 class="title">Selective reporting</h4> <p>In order to detect apparent reporting bias, we observed if the authors mentioned an outcome in their objective or methodology section but then failed to report it, or they reported a primary or secondary outcome without indicating that this was intended. We also noted when the authors failed to report on hypertension and tachycardia. Of the included studies, 13 mentioned a relevant outcome in the aims or methodology (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0024" title="JakobsenCJ , BlomL . Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology1992;9:209‐15. [PUBMED: 1600972] ">Jakobsen 1992</a>; <a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0034" title="LindgrenL , SarnivaraL , KlemolaUM . Protection by fentanyl against cardiac dysrhythmias during induction of anaesthesia. European Journal of Anaesthesiology1987;4:229‐33. [PUBMED: 3653018] ">Lindgren 1987</a>; <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0054" title="OxornD , KnoxJW , HillJ . Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesia1990;37:206‐9. [PUBMED: 1968784] ">Oxorn 1990</a>; <a href="./references#CD004087-bbs2-0059" title="RyhanenP , SaarelaE , SaukkonenJ , HollmenA . Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. Annales Chirurgiae et Gynaecologiae1977;66:294‐8. [PUBMED: 603221] ">Ryhanen 1977</a>; <a href="./references#CD004087-bbs2-0060" title="ScheininB , ScheininM , VuorinenJ , LindgrenL . Alfentanil obtunds the cardiovascular and sympathoadrenal responses to suxamethonium‐facilitated laryngoscopy and intubation. British Journal of Anaesthesia1989;62:385‐92. [PUBMED: 2495811] ">Scheinin 1989</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>; <a href="./references#CD004087-bbs2-0072" title="ZargarJA , NaqashIA , GurcooSA . Comparative evaluation of the effect of metoprolol and esmolol on rate pressure product and ECG changes during laryngoscopy and endotracheal intubation in controlled hypertensives patients. Indian Journal of Anaesthesia2002;46:365‐8. ">Zargar 2002</a>); 59 trials mentioned outcomes only in the results. All of these articles also mentioned the associated changes in blood pressure and heart rate. </p> </section> </section> <section id="CD004087-sec-0065"> <h3 class="title" id="CD004087-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD004087-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>In total, 60 trials looked for arrhythmias (data from two trials were not included (<a href="./references#CD004087-bbs2-0024" title="JakobsenCJ , BlomL . Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology1992;9:209‐15. [PUBMED: 1600972] ">Jakobsen 1992</a>; <a href="./references#CD004087-bbs2-0059" title="RyhanenP , SaarelaE , SaukkonenJ , HollmenA . Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. Annales Chirurgiae et Gynaecologiae1977;66:294‐8. [PUBMED: 603221] ">Ryhanen 1977</a>)) and enrolled 2932 participants, with 1939 participants allocated to receive an intervention. Of the included studies, 31 trials looked at myocardial ischaemia (data from two trials were not included (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>)) and enrolled 1616 participants, with 1012 allocated to receive an intervention. </p> <section id="CD004087-sec-0066"> <h4 class="title">Outcomes</h4> </section> <section id="CD004087-sec-0067"> <h4 class="title">Primary outcome</h4> <section id="CD004087-sec-0068"> <h5 class="title">1. Mortality</h5> <p>Only one study reported mortality as an outcome (<a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>). The author stated that there were no deaths reported in a multicentre trial of 548 patients who received either placebo or esmolol in a dose of 100 or 200 mg for controlling the haemodynamic response. This trial did not mention either arrhythmias or myocardial ischaemia as an outcome. </p> </section> <section id="CD004087-sec-0069"> <h5 class="title">2. Major morbidity</h5> <p>Only one study reported morbidity as an outcome (<a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>). The authors stated in the discussion section that 60 patients, who either received placebo, diltiazem, nicardipine, or verapamil, were followed up for morbidity. No specific morbidity or period of follow‐up was identified by the author. This trial additionally mentioned arrhythmias as an outcome. </p> </section> </section> <section id="CD004087-sec-0070"> <h4 class="title">Secondary outcomes</h4> <p>Arrhthymias only were observed as an outcome in 40 trials, 11 trials observed only myocardial ischaemia as an outcome, and 20 trials observed both arrhythmias and myocardial ischaemia. </p> </section> <section id="CD004087-sec-0071"> <h4 class="title">Outcome 1. Arrhythmias</h4> <section id="CD004087-sec-0072"> <h5 class="title">1.1 All studies reporting arrhythmias, with subgroup analysis by drug type</h5> <p>This outcome was reported by 60 studies. The analysis from two studies was not included (<a href="./references#CD004087-bbs2-0024" title="JakobsenCJ , BlomL . Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology1992;9:209‐15. [PUBMED: 1600972] ">Jakobsen 1992</a>; <a href="./references#CD004087-bbs2-0059" title="RyhanenP , SaarelaE , SaukkonenJ , HollmenA . Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. Annales Chirurgiae et Gynaecologiae1977;66:294‐8. [PUBMED: 603221] ">Ryhanen 1977</a>). The reason for not including the analysis is given under the respective subheadings. </p> <p>Of the 993 participants, 134 (13.4%) in the control group experienced an arrhythmia compared to 80 out of 1939 in the combined active group (4.1%). This difference of 9.2% was statistically significant (the odds of an arrhythmia with an active drug compared to control was: OR 0.19, 95% CI 0.14 to 0.26, P &lt; 0.00001, I<sup>2</sup> = 47%) (<a href="./references#CD004087-fig-0004" title="">Analysis 1.1</a>). </p> <p>The test for a subgroup difference showed a P value of 0.15 (I<sup>2</sup> = 41.4%). </p> <p>A list of all drugs used in these studies reporting arrhythmias, and their dosages, is given in <a href="./appendices#CD004087-sec-0128">Appendix 6</a> . </p> <section id="CD004087-sec-0073"> <h6 class="title">Local anaesthetics</h6> <p>Arrhythmia was reported as an outcome with the use of local anaesthetics in 15 studies (<a href="./references#CD004087-bbs2-0004" title="ArtruAA , StrumwasserTA . Intratracheal aerosolized etidocaine to attenuate cardiovascular and cough responses to laryngoscopy and intubation. Annals of Emergency Medicine1985;14:1069‐73. [PUBMED: 4051271] ">Artru 1985</a>; <a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>; <a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>; <a href="./references#CD004087-bbs2-0018" title="DurraniM , BarwiseJA , JohnsonRF , KambamJR , JanickiPK . Intravenous chloroprocaine attenuates hemodynamic changes associated with direct laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:1208‐12. [PUBMED: 10781481] ">Durrani 2000</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0024" title="JakobsenCJ , BlomL . Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology1992;9:209‐15. [PUBMED: 1600972] ">Jakobsen 1992</a>; <a href="./references#CD004087-bbs2-0028" title="KindlerCH , SchumacherPG , SchneiderMC , UrwylerA . Effects of intravenous lidocaine and/or esmolol on hemodynamic responses to laryngoscopy and intubation: a double‐blind, controlled clinical trial. Journal of Clinical Anesthesia1996;8:491‐6. [PUBMED: 8872690] ">Kindler 1996</a>; <a href="./references#CD004087-bbs2-0055" title="PouttuJ , TuominenMK , RosenbergPH . Cardiovascular responses caused by the combination of lidocaine and vecuronium in the induction of general anaesthesia. Acta Anaesthesiologica Scandinavica1988;32:549‐52. [PUBMED: 2903604] ">Pouttu 1988</a>; <a href="./references#CD004087-bbs2-0059" title="RyhanenP , SaarelaE , SaukkonenJ , HollmenA . Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. Annales Chirurgiae et Gynaecologiae1977;66:294‐8. [PUBMED: 603221] ">Ryhanen 1977</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0063" title="SklarBZ , LurieS , EzriT , KrichelliD , SavirI , SorokerD . Lidocaine inhalation attenuates the circulatory response to laryngoscopy and endotracheal intubation. Journal of Clinical Anesthesia1992;4:382‐5. [PUBMED: 1389192] ">Sklar 1992</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>; <a href="./references#CD004087-bbs2-0069" title="VictoryRA , GajrajNM , PaceNA , OstmanLP . Nebulized bupivacaine attenuates the heart rate responses following tracheal intubation. Journal of Clinical Anaesthesia1995;7:9‐13. [PUBMED: 7772369] ">Victory 1995</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). An analysis of 13 of the 15 studies is included in this review. Different doses and different routes of administration of drugs were used. The largest group was lignocaine. Of these studies, 10 investigated lignocaine in different doses with different routes (spray 4%, spray 10%, 100 mg IV, 1 mg kg<sup>‐1</sup> IV, 1.5 mg kg<sup>‐1</sup> IV, 2 mg kg<sup>‐1</sup> IV, 40 mg inhalational) and different times of administration in relation to tracheal intubation (<a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>; <a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0028" title="KindlerCH , SchumacherPG , SchneiderMC , UrwylerA . Effects of intravenous lidocaine and/or esmolol on hemodynamic responses to laryngoscopy and intubation: a double‐blind, controlled clinical trial. Journal of Clinical Anesthesia1996;8:491‐6. [PUBMED: 8872690] ">Kindler 1996</a>; <a href="./references#CD004087-bbs2-0055" title="PouttuJ , TuominenMK , RosenbergPH . Cardiovascular responses caused by the combination of lidocaine and vecuronium in the induction of general anaesthesia. Acta Anaesthesiologica Scandinavica1988;32:549‐52. [PUBMED: 2903604] ">Pouttu 1988</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0063" title="SklarBZ , LurieS , EzriT , KrichelliD , SavirI , SorokerD . Lidocaine inhalation attenuates the circulatory response to laryngoscopy and endotracheal intubation. Journal of Clinical Anesthesia1992;4:382‐5. [PUBMED: 1389192] ">Sklar 1992</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). One study used 0.75% bupivacaine via aerosol (<a href="./references#CD004087-bbs2-0069" title="VictoryRA , GajrajNM , PaceNA , OstmanLP . Nebulized bupivacaine attenuates the heart rate responses following tracheal intubation. Journal of Clinical Anaesthesia1995;7:9‐13. [PUBMED: 7772369] ">Victory 1995</a>) and one used etidocaine 50 mg and 70 mg via aerosol (<a href="./references#CD004087-bbs2-0004" title="ArtruAA , StrumwasserTA . Intratracheal aerosolized etidocaine to attenuate cardiovascular and cough responses to laryngoscopy and intubation. Annals of Emergency Medicine1985;14:1069‐73. [PUBMED: 4051271] ">Artru 1985</a>). One study compared 4.5 mg kg<sup>‐1</sup> IV chloroprocaine with placebo (<a href="./references#CD004087-bbs2-0018" title="DurraniM , BarwiseJA , JohnsonRF , KambamJR , JanickiPK . Intravenous chloroprocaine attenuates hemodynamic changes associated with direct laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:1208‐12. [PUBMED: 10781481] ">Durrani 2000</a>). </p> <p>Of 362 participants, 29 (8%) in the local anaesthetic group experienced an arrhythmia compared to 32 out of 188 (17.0%) in the control group. This difference of 9.0% was statistically significant (the odds of an arrhythmia with local anaesthetic pretreatment compared to control therapy: OR 0.34, 95% CI 0.18 to 0.62, P = 0.0006, I<sup>2</sup> = 79%) (<a href="./references#CD004087-fig-0004" title="">Analysis 1.1</a>). </p> <p>We considered subgroup analysis by the individual agents within this group but there were insufficient data to make such a comparison meaningful since different routes and different dosages of drugs were used.  </p> </section> <section id="CD004087-sec-0074"> <h6 class="title">Calcium channel blockers</h6> <p>Arrhythmia was reported as an outcome by 11 studies using calcium channel blockers (<a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a>; <a href="./references#CD004087-bbs2-0006" title="AtleeJL , DhameeMS , OlundTL , GeorgeV . The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:280‐5. [PUBMED: 10648307] ">Atlee 2000</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0035" title="MaekawaN , MikawaK , HasegawaM , KaetsuH , GotoR , YakuH , et al. Partial attenuation to the cardiovascular responses to tracheal intubation with oral nisoldipine. Journal of Clinical Anaesthesia1992;4:297‐300. [PUBMED: 1358133] ">Maekawa 1992</a>; <a href="./references#CD004087-bbs2-0036" title="MaekawaN , MikawaK , NishinaK , KaetsuH , GotoR , YakuH , et al. Attenuation of the pressor response to tracheal intubation with oral nitrendipine. Acta Anaesthesiologica Scandinavica1993;37:668‐71. [PUBMED: 8249556] ">Maekawa 1993</a>; <a href="./references#CD004087-bbs2-0042" title="MikawaK , IkegakiJ , MaekawaN , GotoR , KaetsuH , ObaraH . The effect of diltiazem on the cardiovascular response to tracheal intubation. Anaesthesia1990;45:289‐93. [PUBMED: 2337212] ">Mikawa 1990a</a>; <a href="./references#CD004087-bbs2-0043" title="MikawaK , ObaraH , KusunokiM . Effect of nicardipine on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1990;64:240‐2. [PUBMED: 2317427] ">Mikawa 1990b</a>; <a href="./references#CD004087-bbs2-0046" title="MikawaK , MaekawaN , HasegawaM , KaetsuH , GotoR Hideaki Y , et al. Effects of Nilvadipine on the cardiovascular responses to tracheal intubation. Journal of Clinical Anaesthesia1992;4:292‐6. [PUBMED: 1358132] ">Mikawa 1992a</a>; <a href="./references#CD004087-bbs2-0049" title="MikawaK , MaekawaN , NishinaK , HasegawaM , KaestuH , GotoR , et al. Partial attenuation of the cardiovascular responses to tracheal intubation with oral manidipine. Acta Anaesthesiologica Scandinavica1994;38:266‐70. [PUBMED: 7912878] ">Mikawa 1994</a>; <a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>; <a href="./references#CD004087-bbs2-0056" title="PuriGD , SinghSP , SinghH , BatraYK . Attenuation of pulse rate and blood pressure‐response to laryngoscopy and intubation with verapamil. Indian Journal of Medical Research1986;84:548‐51. [PUBMED: 3557578] ">Puri 1986</a>). Two of the studies administered verapamil 0.1 mg kg<sup>‐1</sup> IV (<a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>; <a href="./references#CD004087-bbs2-0056" title="PuriGD , SinghSP , SinghH , BatraYK . Attenuation of pulse rate and blood pressure‐response to laryngoscopy and intubation with verapamil. Indian Journal of Medical Research1986;84:548‐51. [PUBMED: 3557578] ">Puri 1986</a>); two studies diltiazem 0.2 mg kg<sup>‐1</sup>, 0.3 mg kg<sup>‐1</sup> IV (<a href="./references#CD004087-bbs2-0042" title="MikawaK , IkegakiJ , MaekawaN , GotoR , KaetsuH , ObaraH . The effect of diltiazem on the cardiovascular response to tracheal intubation. Anaesthesia1990;45:289‐93. [PUBMED: 2337212] ">Mikawa 1990a</a>; <a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>); three studies nicardipine 15 µg kg<sup>‐1</sup>, 30 µg kg<sup>‐1</sup> IV (<a href="./references#CD004087-bbs2-0006" title="AtleeJL , DhameeMS , OlundTL , GeorgeV . The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:280‐5. [PUBMED: 10648307] ">Atlee 2000</a>; <a href="./references#CD004087-bbs2-0043" title="MikawaK , ObaraH , KusunokiM . Effect of nicardipine on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1990;64:240‐2. [PUBMED: 2317427] ">Mikawa 1990b</a>; <a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>); two studies nifedipine 10 mg sublingual (<a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>); and one each with oral nisoldipine 5 mg and 10 mg (<a href="./references#CD004087-bbs2-0035" title="MaekawaN , MikawaK , HasegawaM , KaetsuH , GotoR , YakuH , et al. Partial attenuation to the cardiovascular responses to tracheal intubation with oral nisoldipine. Journal of Clinical Anaesthesia1992;4:297‐300. [PUBMED: 1358133] ">Maekawa 1992</a>), oral nivaldipine 2 mg and 4 mg (<a href="./references#CD004087-bbs2-0046" title="MikawaK , MaekawaN , HasegawaM , KaetsuH , GotoR Hideaki Y , et al. Effects of Nilvadipine on the cardiovascular responses to tracheal intubation. Journal of Clinical Anaesthesia1992;4:292‐6. [PUBMED: 1358132] ">Mikawa 1992a</a>), oral manidepine 5 mg and 10 mg (<a href="./references#CD004087-bbs2-0049" title="MikawaK , MaekawaN , NishinaK , HasegawaM , KaestuH , GotoR , et al. Partial attenuation of the cardiovascular responses to tracheal intubation with oral manidipine. Acta Anaesthesiologica Scandinavica1994;38:266‐70. [PUBMED: 7912878] ">Mikawa 1994</a>), nitrandepine 5 mg and 10 mg (<a href="./references#CD004087-bbs2-0036" title="MaekawaN , MikawaK , NishinaK , KaetsuH , GotoR , YakuH , et al. Attenuation of the pressor response to tracheal intubation with oral nitrendipine. Acta Anaesthesiologica Scandinavica1993;37:668‐71. [PUBMED: 8249556] ">Maekawa 1993</a>). </p> <p>Of 128 participants, 11 (8.5%) in the control group experienced an arrhythmia compared to three out of 253 (1.18%) in the intervention group. This difference of 7.3% was statistically significant (the odds of an arrhythmia with calcium channel blocker pretreatment compared to control: OR 0.13, 95% CI 0.04 to 0.41, P = 0.0004, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0004" title="">Analysis 1.1</a>). We considered subgroup analysis by the individual agents within this group but there were insufficient data to make such a comparison meaningful. </p> </section> <section id="CD004087-sec-0075"> <h6 class="title">Sympathetic blockers</h6> <p>Arrhythmia as an outcome was reported in 18 studies with sympathetic blockers. The largest group was beta blockers (14 studies). Three studies (<a href="./references#CD004087-bbs2-0003" title="AmarD , ShamoonH , FrishmanWH , LazarEJ , SalamaMD . Effects of labetalol on perioperative stress markers and isoflurane requirements. British Journal of Anaesthesia1991;67:296‐301. [PUBMED: 1911016] ">Amar 1991</a>; <a href="./references#CD004087-bbs2-0008" title="BernsteinJS , EbertTJ , StoweDF , SchmelingWT , NelsonMA , WoodsMP . Partial attenuation of hemodynamic responses to rapid sequence induction and intubation with labetalol. Journal of Clinical Anesthesia1989;1:444‐51. [PUBMED: 2696507] ">Bernstein 1989</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>) reported on arrhythmias with combined alpha and beta blockers and one reported on arrhythmias with alpha blockers (<a href="./references#CD004087-bbs2-0058" title="QuereJF , OzierY , BringierJ , MorotB , ConseillerC . Does urapidil attenuate the blood pressure response to tracheal intubation for general anaesthesia. Drugs1990;40:80‐1. [PUBMED: 2092977] ">Quere 1990</a>). </p> <p>One study had two interventional arms, one with beta blockers and another with combined alpha and beta blockers (<a href="./references#CD004087-bbs2-0039" title="MaharajRJ , ThompsonM , Brock‐UtneJG , WilliamsonR , DowningJW . Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo. South African Medical Journal1983;63:691‐4. [PUBMED: 17408055] ">Maharaj 1983</a>). </p> <p>Of 470 participants, 19 (4%) in the sympathetic blocker group experienced an arrhythmia compared to 34 out of 272 (12.5%) in the control group. This difference of 8.5% was statistically significant (the odds of an arrhythmia with sympathetic blocker pretreatment compared to control therapy: OR 0.22 , 95% CI 0.12 to 0.41, P = 0.00001, I <sup>2</sup> = 0%. The test for a subgroup difference was not significant (P = 0.62, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0005" title="">Analysis 1.2</a>). </p> <p>In addition to the above mentioned studies , Jakobson (<a href="./references#CD004087-bbs2-0024" title="JakobsenCJ , BlomL . Effect of preoperative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. European Journal of Anaesthesiology1992;9:209‐15. [PUBMED: 1600972] ">Jakobsen 1992</a>) looked at the effect of 100 mg oral metoprolol administered preoperatively, and Ryhanen (<a href="./references#CD004087-bbs2-0059" title="RyhanenP , SaarelaE , SaukkonenJ , HollmenA . Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. Annales Chirurgiae et Gynaecologiae1977;66:294‐8. [PUBMED: 603221] ">Ryhanen 1977</a>) studied the effect of 0.02 mg kg<sup>‐1</sup> IV practolol. The results of both of these studies have not been included in the analysis. Jacobson observed arrhythmias throughout the perioperative period and did not differentiate between arrhythmias following tracheal intubation and the rest of the perioperative period. Ryhanen used atropine 0.02 mg kg<sup>‐1</sup> in all patients prior to giving practolol. Some patients had arrhythmias due to the atropine. </p> </section> <section id="CD004087-sec-0076"> <h6 class="title">1.2 Subgroup analysis for sympathetic blockers</h6> <section id="CD004087-sec-0077"> <p><b>Beta blockers</b></p> <p>Arrhythmias were reported as an outcome by 14 studies (<a href="./references#CD004087-bbs2-0006" title="AtleeJL , DhameeMS , OlundTL , GeorgeV . The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesthesia and Analgesia2000;90:280‐5. [PUBMED: 10648307] ">Atlee 2000</a>; <a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0028" title="KindlerCH , SchumacherPG , SchneiderMC , UrwylerA . Effects of intravenous lidocaine and/or esmolol on hemodynamic responses to laryngoscopy and intubation: a double‐blind, controlled clinical trial. Journal of Clinical Anesthesia1996;8:491‐6. [PUBMED: 8872690] ">Kindler 1996</a>; <a href="./references#CD004087-bbs2-0031" title="KorpinenR , SaarnivaaraL , SirenK . QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. Acta Anaesthesiologica Scandinavica1995;39:809‐13. [PUBMED: 7484039] ">Korpinen 1995a</a>; <a href="./references#CD004087-bbs2-0032" title="KorpinenR , SaarnivaaraL , SirenK , SarnaS . Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination. Canadian Journal of Anaesthesia1995;48:298‐304. [PUBMED: 7788827] ">Korpinen 1995b</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0039" title="MaharajRJ , ThompsonM , Brock‐UtneJG , WilliamsonR , DowningJW . Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo. South African Medical Journal1983;63:691‐4. [PUBMED: 17408055] ">Maharaj 1983</a>; <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0044" title="MikawaK , MaekawaN , GotoR , KaetsuH , HasegawaM , YakuH , et al. Effects of pindolol on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1991;67:416‐20. [PUBMED: 1931398] ">Mikawa 1991a</a>; <a href="./references#CD004087-bbs2-0054" title="OxornD , KnoxJW , HillJ . Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesia1990;37:206‐9. [PUBMED: 1968784] ">Oxorn 1990</a>; <a href="./references#CD004087-bbs2-0061" title="SharmaS , GhaniAA , WinN , AhmadM . Comparison of two bolus doses of esmolol for attenuation of haemodynamic response to tracheal intubation. Medical Journal of Malaysia1995;50:372‐6. [PUBMED: 8668059] ">Sharma 1995</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0071" title="WhitePF , WangB , TangJ , WenderRH , NaruseR , SloninskyA . The effect of intraoperative use of esmolol and nicardipine on recovery after ambulatory surgery. Anesthesia and Analgesia2003;97:1633‐8. [PUBMED: 14633533] ">White 2003</a>; <a href="./references#CD004087-bbs2-0072" title="ZargarJA , NaqashIA , GurcooSA . Comparative evaluation of the effect of metoprolol and esmolol on rate pressure product and ECG changes during laryngoscopy and endotracheal intubation in controlled hypertensives patients. Indian Journal of Anaesthesia2002;46:365‐8. ">Zargar 2002</a>). Ten studies investigated esmolol in different doses and with different regimens (25 mg IV, 50 mg IV, 100 mg IV, 200 mg IV, 2 µg kg<sup>‐1</sup> IV, 3 µg kg<sup>‐1</sup> IV, 1.4 mg kg<sup>‐1</sup> IV, 1 mg kg<sup>‐1</sup> IV, 500 µg bolus IV injection followed by infusion), one study investigated pindolol (2 µg kg<sup>‐1</sup>, 4 µg kg<sup>‐1</sup> IV), two studies metoprolol (4 mg IV, 15 mg IV), and one practolol (0.4 mg kg<sup>‐1</sup> IV). </p> <p>Of 218 participants in the control group, 31 (14.2%) experienced an arrhythmia compared to 18 out of 371 (4.8%) in the experimental group. This difference of 9.4% was statistically significant (the odds of an arrhythmia with beta blocker pretreatment compared to the control therapy: OR 0.23, 95% CI 0.12 to 0.44, P = 0.0001, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0005" title="">Analysis 1.2</a>). We considered further subgroup analysis by specific doses within this group but there were insufficient data to make such a comparison meaningful. </p> </section> <section id="CD004087-sec-0078"> <p><b>Combined alpha and beta blockers</b></p> <p>Four studies reported arrhythmias as an outcome with labetalol in the following doses: 0.15, 0.25, 0.5, 0.75 mgkg<sup>‐1</sup> IV; 5 mg, 10 mg bolus IV (<a href="./references#CD004087-bbs2-0003" title="AmarD , ShamoonH , FrishmanWH , LazarEJ , SalamaMD . Effects of labetalol on perioperative stress markers and isoflurane requirements. British Journal of Anaesthesia1991;67:296‐301. [PUBMED: 1911016] ">Amar 1991</a>; <a href="./references#CD004087-bbs2-0008" title="BernsteinJS , EbertTJ , StoweDF , SchmelingWT , NelsonMA , WoodsMP . Partial attenuation of hemodynamic responses to rapid sequence induction and intubation with labetalol. Journal of Clinical Anesthesia1989;1:444‐51. [PUBMED: 2696507] ">Bernstein 1989</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0039" title="MaharajRJ , ThompsonM , Brock‐UtneJG , WilliamsonR , DowningJW . Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo. South African Medical Journal1983;63:691‐4. [PUBMED: 17408055] ">Maharaj 1983</a>). Three out of 29 (10.3%) participants in the control group experienced an arrhythmia compared to one out of 74 (1.3%) in the labetalol group. This difference of 9.0% was not statistically significant (the odds of an arrhythmia with labetalol pretreatment compared to control therapy: OR 0.13, 95% CI 0.01 to 1.17, P = 0.07, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD004087-sec-0079"> <p><b>Ganglion blockers</b></p> <p>No study was identified in this subgroup.</p> </section> <section id="CD004087-sec-0080"> <p><b>Alpha blockers</b></p> <p>Only one study reported arrhythmias as an outcome in this group, using urapidil (<a href="./references#CD004087-bbs2-0058" title="QuereJF , OzierY , BringierJ , MorotB , ConseillerC . Does urapidil attenuate the blood pressure response to tracheal intubation for general anaesthesia. Drugs1990;40:80‐1. [PUBMED: 2092977] ">Quere 1990</a>). There were no positive outcomes (<a href="./references#CD004087-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD004087-sec-0081"> <h6 class="title">Centrally acting alpha agonists</h6> <p>Three studies reported arrhythmia as an outcome using clonidine (0.3 mg oral, 1.25 and 0.625 µg kg<sup>‐1</sup> IV) and gunabenz (4 and 6 mg oral) (<a href="./references#CD004087-bbs2-0010" title="CarabineUA , WrightPM , HoweJP , MooreJ . Cardiovascular effects of intravenous clonidine. Partial attenuation of the pressor response to intubation by clonidine. Anaesthesia1991;46:634‐7. [PUBMED: 1887968] ">Carabine 1991</a>; <a href="./references#CD004087-bbs2-0048" title="MikawaK , MaekawaN , HasegawaM , KaetsuH , GotoR , YakuH , et al. Attenuation of the cardiovascular and catecholamine responses to tracheal intubation with oral guanabenz. Anesthesia and Analgesia1993;76:585‐91. [PUBMED: 8095779] ">Mikawa 1993</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>). One out of 36 (2.7%) participants in the control group experienced an arrhythmia compared to none out of 72 in the treatment group. This difference of 2.7% was not statistically significant (the odds of an arrhythmia with a centrally acting alpha agonist pretreatment compared to control therapy: OR 0.05, 95% CI 0.00 to 3.18, P = 0.16, heterogeneity not applicable) (<a href="./references#CD004087-fig-0004" title="">Analysis 1.1</a>). </p> <p>All these studies were blinded and in low risk patients.</p> </section> <section id="CD004087-sec-0082"> <h6 class="title">Peripheral vasodilators</h6> <p>Three studies reported arrhythmias (<a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0047" title="MikawaK , HasegawaM , SuzukiT , MaekawaN , KaetsuH , GotoR , et al. Attenuation of hypertensive response to tracheal intubation with nitroglycerin. Journal of Clinical Anesthesia1992;4:367‐71. [PUBMED: 1389189] ">Mikawa 1992b</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>). Nitroglycerine was used in the following doses: 1.5 µg kg<sup>‐1</sup>, 2 µg kg<sup>‐1</sup> or 2.5 µg kg<sup>‐1</sup>, 5 µg kg<sup>‐1</sup> IV; or 2% transdermally. None of the participants in the control group or in the treatment group experienced arrhythmias. </p> </section> <section id="CD004087-sec-0083"> <h6 class="title">Narcotics</h6> <p>Arrhythmia was reported as an outcome by 12 studies (<a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a>; <a href="./references#CD004087-bbs2-0009" title="BlackTE , KayB , HealyTE . Reducing the haemodynamic responses to laryngoscopy and intubation. A comparison of alfentanil with fentanyl. Anaesthesia1984;39:883‐7. [PUBMED: 6443596] ">Black 1984</a>; <a href="./references#CD004087-bbs2-0012" title="CrawfordDC , FellD , AcholaKJ , SmithG . Effects of alfentanil on the pressor and catecholamine responses to tracheal intubation. British Journal of Anaesthesia1987;59:707‐12. [PUBMED: 3111508] ">Crawford 1987</a>; <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a>; <a href="./references#CD004087-bbs2-0026" title="KayB , NolanD , MayallR , HealyTEJ . The effect of sufentanil on the cardiovascular responses to tracheal intubation. Anaesthesia1987;42:382‐6. [PUBMED: 2884895] ">Kay1987</a>; <a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0031" title="KorpinenR , SaarnivaaraL , SirenK . QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. Acta Anaesthesiologica Scandinavica1995;39:809‐13. [PUBMED: 7484039] ">Korpinen 1995a</a>; <a href="./references#CD004087-bbs2-0032" title="KorpinenR , SaarnivaaraL , SirenK , SarnaS . Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination. Canadian Journal of Anaesthesia1995;48:298‐304. [PUBMED: 7788827] ">Korpinen 1995b</a>; <a href="./references#CD004087-bbs2-0034" title="LindgrenL , SarnivaraL , KlemolaUM . Protection by fentanyl against cardiac dysrhythmias during induction of anaesthesia. European Journal of Anaesthesiology1987;4:229‐33. [PUBMED: 3653018] ">Lindgren 1987</a>; <a href="./references#CD004087-bbs2-0060" title="ScheininB , ScheininM , VuorinenJ , LindgrenL . Alfentanil obtunds the cardiovascular and sympathoadrenal responses to suxamethonium‐facilitated laryngoscopy and intubation. British Journal of Anaesthesia1989;62:385‐92. [PUBMED: 2495811] ">Scheinin 1989</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>). Four studies investigated alfentanil in different doses: 75 µg IV bolus, 0.03 mg kg<sup>‐1</sup> IV, 10 µg kg<sup>‐1</sup> IV, 15 µg kg<sup>‐1</sup> IV, 30 µg kg<sup>‐1</sup> IV, 40 µg kg<sup>‐1</sup> IV (<a href="./references#CD004087-bbs2-0012" title="CrawfordDC , FellD , AcholaKJ , SmithG . Effects of alfentanil on the pressor and catecholamine responses to tracheal intubation. British Journal of Anaesthesia1987;59:707‐12. [PUBMED: 3111508] ">Crawford 1987</a>; <a href="./references#CD004087-bbs2-0031" title="KorpinenR , SaarnivaaraL , SirenK . QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. Acta Anaesthesiologica Scandinavica1995;39:809‐13. [PUBMED: 7484039] ">Korpinen 1995a</a>; <a href="./references#CD004087-bbs2-0032" title="KorpinenR , SaarnivaaraL , SirenK , SarnaS . Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination. Canadian Journal of Anaesthesia1995;48:298‐304. [PUBMED: 7788827] ">Korpinen 1995b</a>; <a href="./references#CD004087-bbs2-0060" title="ScheininB , ScheininM , VuorinenJ , LindgrenL . Alfentanil obtunds the cardiovascular and sympathoadrenal responses to suxamethonium‐facilitated laryngoscopy and intubation. British Journal of Anaesthesia1989;62:385‐92. [PUBMED: 2495811] ">Scheinin 1989</a>); six reported on fentanyl (1 µg kg<sup>‐1</sup> IV, 1.5 µg kg<sup>‐1</sup> IV, 2 µg kg<sup>‐1</sup> IV, 3 µg kg<sup>‐1</sup> IV, 5 µg kg<sup>‐1</sup> IV; 0.8 µg kg<sup>‐1</sup> infusion) (<a href="./references#CD004087-bbs2-0001" title="Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1991;11:63‐72. [PUBMED: 2067506] Abdel‐RazekA , El‐AttarAM . Nifedipine versus fentanyl to prevent the pressor response to tracheal intubation. Middle East Journal of Anesthesia1995;13:89‐99. [PUBMED: 7565425] ">Abdel‐Razek 1991</a>; <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a>; <a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0034" title="LindgrenL , SarnivaraL , KlemolaUM . Protection by fentanyl against cardiac dysrhythmias during induction of anaesthesia. European Journal of Anaesthesiology1987;4:229‐33. [PUBMED: 3653018] ">Lindgren 1987</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>); and one studied sufentanil (0.5 µg kg<sup>‐1</sup>, 1 µg kg<sup>‐1</sup>) (<a href="./references#CD004087-bbs2-0026" title="KayB , NolanD , MayallR , HealyTEJ . The effect of sufentanil on the cardiovascular responses to tracheal intubation. Anaesthesia1987;42:382‐6. [PUBMED: 2884895] ">Kay1987</a>). One study was a multi‐arm study (<a href="./references#CD004087-bbs2-0009" title="BlackTE , KayB , HealyTE . Reducing the haemodynamic responses to laryngoscopy and intubation. A comparison of alfentanil with fentanyl. Anaesthesia1984;39:883‐7. [PUBMED: 6443596] ">Black 1984</a>) comparing fentanyl and alfentanil. </p> <p>Of the 166 participants in the control group, 56 (33.7%) experienced an arrhythmia compared to 29 out of 454 (6.3%) in the intervention group. This difference of 27.4% was statistically significant (the odds of an arrhythmia with pretreatment with a narcotic compared to control therapy: OR 0.12, 95% CI 0.07 to 0.21, P &lt; 0.00001, I<sup>2</sup> = 58%) (<a href="./references#CD004087-fig-0004" title="">Analysis 1.1</a>). We considered subgroup analysis by individual agents and dosages within this group but there were insufficient data to make such comparisons meaningful. </p> </section> <section id="CD004087-sec-0084"> <h6 class="title">ACE inhibitors</h6> <p>No study was identified for inclusion in this group.</p> </section> <section id="CD004087-sec-0085"> <h6 class="title">Miscellaneous drugs</h6> <p>Eight studies reported arrhythmias as an outcome (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0007" title="BafnaU , GoyalVK , GargA . A comparison of different doses of gabapentin to attenuate the haemodynamic response to laryngoscopy and tracheal intubation in normotensive patients. Journal of Anaesthesiology Clinical Pharmacology2011;27:43‐6. [PUBMED: 21804705] ">Bafna 2011</a>; <a href="./references#CD004087-bbs2-0027" title="KayaFN , YavascaogluB , BaykaraM , AltunGT , GülhanN , AtaF . Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. Acta Anaesthesiologica Scandinavica2008;52:1076‐80. [PUBMED: 18840107] ">Kaya 2008</a>; <a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>; <a href="./references#CD004087-bbs2-0041" title="MemisD , TuranA , KaramanlioqluB , SekerS , TüreM . Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesia2006;23:686‐90. [PUBMED: 16805934] ">Memis 2006</a>; <a href="./references#CD004087-bbs2-0045" title="MikawaK , MaekawaN , KaetsuH , GotoR , YakuH , OboraH . Effects of adenosine triphosphate on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1991;67:410‐5. [PUBMED: 1931397] ">Mikawa 1991b</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>). None of the patients in the control or the treatment groups experienced an arrhythmia.  </p> <p>Six of these studies used oral gabapentin (400, 600, 800, 1000 and 1200 mg) (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0007" title="BafnaU , GoyalVK , GargA . A comparison of different doses of gabapentin to attenuate the haemodynamic response to laryngoscopy and tracheal intubation in normotensive patients. Journal of Anaesthesiology Clinical Pharmacology2011;27:43‐6. [PUBMED: 21804705] ">Bafna 2011</a>; <a href="./references#CD004087-bbs2-0027" title="KayaFN , YavascaogluB , BaykaraM , AltunGT , GülhanN , AtaF . Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. Acta Anaesthesiologica Scandinavica2008;52:1076‐80. [PUBMED: 18840107] ">Kaya 2008</a>; <a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>; <a href="./references#CD004087-bbs2-0041" title="MemisD , TuranA , KaramanlioqluB , SekerS , TüreM . Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesia2006;23:686‐90. [PUBMED: 16805934] ">Memis 2006</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>). Dexamethasone 8 mg IV was used in the second arm of one study (<a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>). </p> <p>One study reported arrhythmia with ATP (0.05 mg kg<sup>‐1</sup> or 0.1 mg kg<sup>‐1</sup>) as an outcome (<a href="./references#CD004087-bbs2-0045" title="MikawaK , MaekawaN , KaetsuH , GotoR , YakuH , OboraH . Effects of adenosine triphosphate on the cardiovascular response to tracheal intubation. British Journal of Anaesthesia1991;67:410‐5. [PUBMED: 1931397] ">Mikawa 1991b</a>) and another used magnesium sulphate (50 mg kg<sup>‐1</sup>) (<a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>). </p> </section> </section> <section id="CD004087-sec-0086"> <h5 class="title">1.3 All studies reporting arrhythmias, studies including high risk patients versus low risk patients </h5> <p>To investigate the possible influence of baseline risk in these patients we conducted a subgroup analysis to compare those trials enrolling high risk patients only to trials enrolling low risk patients. In the nine studies where high risk patients were enrolled (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0056" title="PuriGD , SinghSP , SinghH , BatraYK . Attenuation of pulse rate and blood pressure‐response to laryngoscopy and intubation with verapamil. Indian Journal of Medical Research1986;84:548‐51. [PUBMED: 3557578] ">Puri 1986</a>), there was a statistically significant difference observed between placebo and the treatment groups for the risk of developing arrhythmias (OR 0.18, 95% CI 0.05 to 0.59, P &lt; 0.005, I<sup>2</sup> = 80%) (<a href="./references#CD004087-fig-0006" title="">Analysis 1.3</a>). In the 49 trials enrolling lower risk patients there was again a significant difference observed between the placebo and treatment groups (OR 0.20, 95% CI 0.14 to 0.28, P &lt; 0.00001, I<sup>2</sup> = 44%) (<a href="./references#CD004087-fig-0006" title="">Analysis 1.3</a>). </p> <p>The test for a subgroup difference showed a P value of 0.86 (I<sup>2</sup> = 0%). </p> </section> </section> <section id="CD004087-sec-0087"> <h4 class="title">Outcome 2. ECG evidence of myocardial ischaemia</h4> <section id="CD004087-sec-0088"> <h5 class="title">2.1 All studies reporting ECG evidence of myocardial ischaemia, by drug type</h5> <p>This outcome was reported by 31 studies, but we analysed 29 studies only. The reason for not including data from two studies (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) is given under the subgroup 'Sympathetic blockers'. Of 604 participants in the control group, 21 (3.4%) showed evidence of the ECG changes of myocardial ischaemia compared to 10 out of 1012 (0.98%) in the treatment group. This difference of 2.4% was significant (the odds of ECG changes of myocardial ischaemia with an active drug compared to control: OR 0.45, 95% CI 0.22 to 0.92, P = 0.03, I<sup>2</sup> = 19%) ( <a href="./references#CD004087-fig-0007" title="">Analysis 2.1</a>). </p> <p>The test for a subgroup difference showed a P value of 0.17 (I<sup>2</sup> = 37.4%).  </p> <p>A list of all the drugs used in these studies and their dosages is given in <a href="./appendices#CD004087-sec-0128">Appendix 6</a>. </p> <section id="CD004087-sec-0089"> <h6 class="title">Local anaesthetics</h6> <p>Four studies used lignocaine (1 mg kg<sup>‐1</sup> IV, 1.5 mg kg<sup>‐1</sup> IV; or inhalation of 5 ml of 2%, 1 mg kg<sup>‐1</sup>, 4% transtracheal, 1 mg kg<sup>‐1</sup>, 10% via atomizer) and reported ischaemic changes in the ECG as an outcome (<a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>). Four patients in the control group compared to none in the treatment group showed ECG evidence of myocardial ischaemia in one study (<a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>). In the other three studies none of the participants in the control group or in the lignocaine group had a positive outcome. Four patients out of 67 (5.9%) in the control group showed evidence of the ECG changes of myocardial ischaemia compared to none out of 125 in the treatment group. This difference of 5.9% was significant (the odds of ECG changes of myocardial ischaemia with an active drug compared to control: OR 0.02, 95% CI 0.00 to 0.16 , P = 0.0004) (<a href="./references#CD004087-fig-0007" title="">Analysis 2.1</a>). </p> </section> <section id="CD004087-sec-0090"> <h6 class="title">Calcium channel blockers</h6> <p>Two studies reported ischaemic changes on the ECG as an outcome (<a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0064" title="SongD , SinghH , WhitePF , GadhialiM , GriffinJD , KleinKW . Optimal dose of Nicardipine for maintenance of hemodynamic stability after tracheal intubation and skin incision. Anesthesia and Analgesia1997;85:1247‐51. [PUBMED: 9390588] ">Song 1997</a>). None of the 35 participants in the control group or the 95 in the treatment with calcium channel blocker (nifedipine, nicardipine, diltiazem) reported ischaemic changes. </p> </section> <section id="CD004087-sec-0091"> <h6 class="title">Sympathetic blockers</h6> <section id="CD004087-sec-0092"> <p><b>Beta blocker</b></p> <p>Ischaemic changes in the ECG were reported by 11 studies as an outcome (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0053" title="NewsomeLR , RothJV , HugCCJr , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65:451‐6. [PUBMED: 3485937] ">Newsome 1986</a>; <a href="./references#CD004087-bbs2-0054" title="OxornD , KnoxJW , HillJ . Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Canadian Journal of Anaesthesia1990;37:206‐9. [PUBMED: 1968784] ">Oxorn 1990</a>; <a href="./references#CD004087-bbs2-0061" title="SharmaS , GhaniAA , WinN , AhmadM . Comparison of two bolus doses of esmolol for attenuation of haemodynamic response to tracheal intubation. Medical Journal of Malaysia1995;50:372‐6. [PUBMED: 8668059] ">Sharma 1995</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0072" title="ZargarJA , NaqashIA , GurcooSA . Comparative evaluation of the effect of metoprolol and esmolol on rate pressure product and ECG changes during laryngoscopy and endotracheal intubation in controlled hypertensives patients. Indian Journal of Anaesthesia2002;46:365‐8. ">Zargar 2002</a>). Of these studies, 10 had investigated esmolol in different doses. Eight out of 190 (4.2%) of the participants in the control group had ECG evidence of myocardial ischaemia compared to five out of 269 (1.8%) in the treatment group. This difference of 2.4% was not statistically significant (the odds of ECG evidence of myocardial ischaemia with a beta blocker pretreatment compared to control therapy: OR 0.61, 95% CI 0.19 to 1.94, P = 0.41, I<sup>2</sup> = 39 %) (<a href="./references#CD004087-fig-0007" title="">Analysis 2.1</a>). Further subgroup analysis was not considered since 10 of the studies were with esmolol and the data indicated homogeneity. </p> <p>Additionally, one study (<a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) observed the risk of myocardial ischaemia in untreated hypertensive patients who received a single oral dose of labetalol 100 mg, atenolol 50 mg, or oxprenolol 20 mg two hours before induction. We did not include the results of this study in our analysis as the authors reported the overall risk of myocardial ischaemia (seven patients had ischaemia during induction) but did not specify the percentage of patients who had myocardial ischaemia related to tracheal intubation. The anaesthesia technique was also not standardized. </p> <p>Six of the included studies were with high risk patients (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0053" title="NewsomeLR , RothJV , HugCCJr , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65:451‐6. [PUBMED: 3485937] ">Newsome 1986</a>) and four of the included studies were not blinded (<a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0061" title="SharmaS , GhaniAA , WinN , AhmadM . Comparison of two bolus doses of esmolol for attenuation of haemodynamic response to tracheal intubation. Medical Journal of Malaysia1995;50:372‐6. [PUBMED: 8668059] ">Sharma 1995</a>). </p> </section> <section id="CD004087-sec-0093"> <p><b>Combined alpha and beta blockers</b></p> <p>No study was identified in this group.</p> </section> </section> <section id="CD004087-sec-0094"> <h6 class="title">Peripheral vasodilators</h6> <p>Four studies reported ECG evidence of ischaemia (<a href="./references#CD004087-bbs2-0021" title="HartAP , CamporesiEM , SellTL , CroughwellN , SilvaR , JonesRH , et al. The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography. Anesthesia and Analgesia1989;68:718‐23. [PUBMED: 2500040] ">Hart 1989</a>; <a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>; <a href="./references#CD004087-bbs2-0068" title="ThomsonIR , MutchWA , CulliganJD . Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischaemia during fentanyl‐pancuronium anesthesia. Anesthesiology1984;61:385‐93. [PUBMED: 6435481] ">Thomson 1984</a>). Five participants in the control group out of 39 (12.8%) compared to five out of 44 (11.3%) patients in the treatment group experienced ischaemic changes on the ECG. This difference of 1.5% was not significant (the odds of ischaemic changes on ECG with nitroglycerine pretreatment: OR 1.47, 95% CI 0.26 to 8.18, P = 0.66). Heterogeneity was not applicable. </p> <p>In addition, one study (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>) looked at haemodynamic responses related to intubation in 21 patients undergoing neurosurgical procedures. Of these patients 10 were pretreated with hydralazine and the others with saline. The authors mentioned the CM5 lead configuration to detect myocardial ischaemia but did not report these results in their study. </p> </section> <section id="CD004087-sec-0095"> <h6 class="title">Centrally acting alpha agonists</h6> <p>Only one study reported ischaemic changes on the ECG as an outcome in this group (<a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>). There were no positive outcomes, therefore we did not perform an analysis. </p> </section> <section id="CD004087-sec-0096"> <h6 class="title">Narcotics</h6> <p>Six studies (<a href="./references#CD004087-bbs2-0011" title="Chraemmer‐JørgensenB , Høilund‐CarlsenPF , Bjerre‐JepsenK , HertelS , MarvingJ , StrømJ , et al. Does alfentanil preserve left ventricular pump function during rapid sequence induction of anaesthesia?. Acta Anaesthesiologica Scandinavica1992;36:362‐8. [PUBMED: 1595343] ">Chraemmer‐Jorgensen 1992</a>; <a href="./references#CD004087-bbs2-0012" title="CrawfordDC , FellD , AcholaKJ , SmithG . Effects of alfentanil on the pressor and catecholamine responses to tracheal intubation. British Journal of Anaesthesia1987;59:707‐12. [PUBMED: 3111508] ">Crawford 1987</a>; <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>) were identified in this group. Two of the studies were in high risk patients (<a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>). None of the patients in the treatment group experienced ECG evidence of ischaemia. One patient in the control group experienced ECG evidence of ischaemia. This difference of 0.7% was not significant (the odds of ECG changes of myocardial ischaemia with an active drug compared to control: OR 0.14, 95% CI 0.00 to 6.82, P = 0.32, I<sup>2</sup> not applicable) (<a href="./references#CD004087-fig-0007" title="">Analysis 2.1</a>).      </p> </section> <section id="CD004087-sec-0097"> <h6 class="title">ACE inhibitors</h6> <p>No study was identified in this group.</p> </section> <section id="CD004087-sec-0098"> <h6 class="title">Miscellaneous drugs</h6> <p>Six studies were identified in this group (<a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>; <a href="./references#CD004087-bbs2-0027" title="KayaFN , YavascaogluB , BaykaraM , AltunGT , GülhanN , AtaF . Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. Acta Anaesthesiologica Scandinavica2008;52:1076‐80. [PUBMED: 18840107] ">Kaya 2008</a>; <a href="./references#CD004087-bbs2-0030" title="KoçS , MemisD , SutN . The preoperative use of gabapentin, dexamethasone, and their combination in varicocoele surgery: a randomised controlled trial. Anesthesia and Analgesia2007;105:1137‐42. [PUBMED: 17898401] ">Koç 2007</a>; <a href="./references#CD004087-bbs2-0041" title="MemisD , TuranA , KaramanlioqluB , SekerS , TüreM . Gabapentin reduces cardiovascular responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesia2006;23:686‐90. [PUBMED: 16805934] ">Memis 2006</a>; <a href="./references#CD004087-bbs2-0052" title="MontazeriK , KashefiP , HonarmandA , SafaviM , HirmanpourA . Attenuation of the pressor response to direct laryngoscopy and tracheal intubation: oral clonidine vs. oral gabapentin premedication. Journal of Research in Medical Sciences2011;16:377‐86. [PUBMED: 22247722] ">Montazeri 2011</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>). Only one study reported a positive outcome on ischaemic ECG changes (<a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>). In this study three participants out of 14 (21.4%) compared to none out of 16 in the magnesium sulphate group showed ECG evidence of ischaemia. Combining all six studies, three of the participants in the control group out of 135 (2.2%) showed evidence of ECG changes of myocardial ischaemia compared to none out of 203 in the treatment group. This difference of 2.2% was significant (the odds of ECG changes of myocardial ischaemia with an active drug compared to control: OR 0.10, 95% CI 0.01 to 1.05, P = 0.05) (<a href="./references#CD004087-fig-0007" title="">Analysis 2.1</a>).  </p> </section> </section> <section id="CD004087-sec-0099"> <h5 class="title">2.2 All studies reporting ECG evidence of myocardial ischaemia, analysis of studies with high risk patients versus low risk patients </h5> <p>Of the studies, 14 (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0021" title="HartAP , CamporesiEM , SellTL , CroughwellN , SilvaR , JonesRH , et al. The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography. Anesthesia and Analgesia1989;68:718‐23. [PUBMED: 2500040] ">Hart 1989</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0053" title="NewsomeLR , RothJV , HugCCJr , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65:451‐6. [PUBMED: 3485937] ">Newsome 1986</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>; <a href="./references#CD004087-bbs2-0068" title="ThomsonIR , MutchWA , CulliganJD . Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischaemia during fentanyl‐pancuronium anesthesia. Anesthesiology1984;61:385‐93. [PUBMED: 6435481] ">Thomson 1984</a>) were in high risk patients. To investigate the possible influence of baseline risk we conducted a subgroup analysis of studies in high risk patients compared to low risk patients, with the exclusion of two studies (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>). In the 12 studies where the high risk patients were enrolled 15 out of 193 participants in the control group (7.7%) and 10 out of 202 in the treatment group (4.9%) had ECG changes of myocardial ischaemia. This difference was not significant (OR 0.67, 95% CI 0.27 to 1.67, P = 0.39, I<sup>2</sup> = 40%) (<a href="./references#CD004087-fig-0008" title="">Analysis 2.2</a>). </p> <p>In the 17 studies enrolling lower risk patients none of the 810 patients in the treatment group had myocardial ischaemia compared to six out of 411 (1.4%) in the control group. This difference was significant (OR 0.03, 95% CI 0.01 to 0.18, P = 0.0001, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0008" title="">Analysis 2.2</a>). </p> <p>The test for a subgroup difference showed a P value of 0.003 (I<sup>2</sup> = 89%). </p> </section> </section> <section id="CD004087-sec-0100"> <h4 class="title">Outcome 3. Adverse effects associated with pharmacological interventions, analysis by drug type </h4> <section id="CD004087-sec-0101"> <h5 class="title">Local anaesthetics</h5> <p>Side effects were reported following lignocaine administration in three trials (<a href="./references#CD004087-bbs2-0055" title="PouttuJ , TuominenMK , RosenbergPH . Cardiovascular responses caused by the combination of lidocaine and vecuronium in the induction of general anaesthesia. Acta Anaesthesiologica Scandinavica1988;32:549‐52. [PUBMED: 2903604] ">Pouttu 1988</a>; <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). One patient in the lignocaine group had bradycardia (heart rate (HR) &lt; 37 beats min<sup>‐ 1</sup> two hours after drug administration) (<a href="./references#CD004087-bbs2-0055" title="PouttuJ , TuominenMK , RosenbergPH . Cardiovascular responses caused by the combination of lidocaine and vecuronium in the induction of general anaesthesia. Acta Anaesthesiologica Scandinavica1988;32:549‐52. [PUBMED: 2903604] ">Pouttu 1988</a>) and two patients had restlessness when given 2 mg kg<sup>‐1</sup> 10 minutes before tracheal intubation (<a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). One study (<a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a>) reported tinnitus with lignocaine 1.5 µg kg<sup>‐1</sup> IV in 48% of participants.  </p> <p>A statistically significant difference was observed between the placebo and treatment groups with 16 patients out of 153 showing adverse effects compared to none in the control group (the odds of side effects with the active drug compared to control therapy: OR 12.27, 95 % CI 4.03 to 37.36, P &lt; 0.0001, I<sup>2</sup> = 0%) (<a href="./references#CD004087-fig-0009" title="">Analysis 3.1</a>). </p> </section> <section id="CD004087-sec-0102"> <h5 class="title">Calcium channel blockers</h5> <p>Hypotension requiring treatment was not observed in any of the studies using calcium channel blockers. In one study (<a href="./references#CD004087-bbs2-0035" title="MaekawaN , MikawaK , HasegawaM , KaetsuH , GotoR , YakuH , et al. Partial attenuation to the cardiovascular responses to tracheal intubation with oral nisoldipine. Journal of Clinical Anaesthesia1992;4:297‐300. [PUBMED: 1358133] ">Maekawa 1992</a>) one patient had flushing following a 5 mg nitrendipine oral dose. </p> </section> <section id="CD004087-sec-0103"> <h5 class="title">Sympathetic blockers</h5> <p>Five trials of sympathetic blockers reported side effects. <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a> reported bradycardia (HR &lt; 50 beats min<sup>‐1</sup>) and bronchospasm in one patient who received a dose of 200 mg esmolol as an IV bolus. In another study, one patient developed hypotension requiring treatment following esmolol 1.4 mg kg<sup>‐1</sup> (<a href="./references#CD004087-bbs2-0062" title="SinghH , VichitvejpaisalP , GainesGY , WhitePF . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. Journal of Clinical Anesthesia1995;7:5‐8. [PUBMED: 7772359] ">Singh 1995</a>). One study reported increased bronchomotor tone and a HR of &lt; 70 beat min<sup>‐1</sup> in two patients with esmolol (<a href="./references#CD004087-bbs2-0061" title="SharmaS , GhaniAA , WinN , AhmadM . Comparison of two bolus doses of esmolol for attenuation of haemodynamic response to tracheal intubation. Medical Journal of Malaysia1995;50:372‐6. [PUBMED: 8668059] ">Sharma 1995</a>). <a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a> reported bronchospasm in four patients who received esmolol 100 and 200 mg IV compared to two patients who received placebo. In <a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a> one patient in the treatment group developed bronchospasm following esmolol infusion 500 µg kg<sup>‐1</sup>, and also in the control group. </p> <p>A statistically significant difference was observed between the placebo and treatment groups with 37 patients out of 156 showing adverse effects in the treatment group compared to one out of 103 in the control group (the odds of side effects with the active drug compared to control therapy: OR 24.17, 95 % CI 8.88 to 65.79, P &lt; 0.00001, I<sup>2</sup> = 63%) (<a href="./references#CD004087-fig-0010" title="">Analysis 3.2</a>). </p> </section> <section id="CD004087-sec-0104"> <h5 class="title">Combined alpha and beta blockers</h5> <p><a href="./references#CD004087-bbs2-0003" title="AmarD , ShamoonH , FrishmanWH , LazarEJ , SalamaMD . Effects of labetalol on perioperative stress markers and isoflurane requirements. British Journal of Anaesthesia1991;67:296‐301. [PUBMED: 1911016] ">Amar 1991</a> reported a transient decrease of the mean arterial pressure (MAP) during surgery in two patients who received labetalol 0.75 µg kg<sup>‐1</sup>. </p> <p><a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a> reported one patient who developed bronchospasm following labetalol 5 mg. </p> </section> <section id="CD004087-sec-0105"> <h5 class="title">Centrally acting alpha agonists</h5> <p>Intravenous clonidine 1.25 µg kg<sup>‐1</sup> in one patient resulted in bradycardia of 45 beats min<sup>‐1</sup> and hypotension five minutes after completion of the study (<a href="./references#CD004087-bbs2-0010" title="CarabineUA , WrightPM , HoweJP , MooreJ . Cardiovascular effects of intravenous clonidine. Partial attenuation of the pressor response to intubation by clonidine. Anaesthesia1991;46:634‐7. [PUBMED: 1887968] ">Carabine 1991</a>). No side effects were seen associated with oral gunabenz. </p> </section> <section id="CD004087-sec-0106"> <h5 class="title">Narcotics</h5> <p><a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a> reported a significant fall in blood pressure (BP) after induction in all patients in the treatment group who received fentanyl (2, 5, 10, and 15 µg kg<sup>‐1</sup>) compared to seven in the control group. <a href="./references#CD004087-bbs2-0065" title="SplinterWM , CervenkoF . Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Canadian Journal of Anaesthesia1989;36:370‐6. [PUBMED: 2758537] ">Splinter 1989</a> reported respiratory depression in one patient who had received fentanyl. </p> <p><a href="./references#CD004087-bbs2-0012" title="CrawfordDC , FellD , AcholaKJ , SmithG . Effects of alfentanil on the pressor and catecholamine responses to tracheal intubation. British Journal of Anaesthesia1987;59:707‐12. [PUBMED: 3111508] ">Crawford 1987</a> reported a 40% fall in MAP and bradycardia following a 40 µg kg<sup>‐1</sup> dose of alfentanil in one ASA 3 patient; this hypotension was resistant to IV fluid and IV atropine. In this study, out of 15 patients 11 received more than 750 ml of fluid to keep the MAP at 60 mm Hg.  </p> <p>In <a href="./references#CD004087-bbs2-0060" title="ScheininB , ScheininM , VuorinenJ , LindgrenL . Alfentanil obtunds the cardiovascular and sympathoadrenal responses to suxamethonium‐facilitated laryngoscopy and intubation. British Journal of Anaesthesia1989;62:385‐92. [PUBMED: 2495811] ">Scheinin 1989</a> a dose of 75 µg kg<sup>‐1</sup> alfentanil resulted in chest rigidity and difficulty in ventilation in 40% of the patients compared to none in the control group. </p> <p>A statistically significant difference was observed between the placebo and treatment groups with 79 patients out of 155 showing adverse effects in the treatment group compared to none out of 63 in the control group (the odds of side effects with the active drug compared to control therapy: OR 149.5, 95 % CI 35.07 to 637.6, P &lt; 0.00001, I<sup>2</sup> = 92%) (<a href="./references#CD004087-fig-0012" title="">Analysis 3.4</a>). </p> </section> <section id="CD004087-sec-0107"> <h5 class="title">Miscellaneous</h5> <p><a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a> reported three patients out of 16 who required pharmacological management of hypotension in the group who received magnesium sulphate 50 mg kg<sup>‐1</sup>. The same participants also expressed a feeling of warmth after the injection. Some patients in the same trial experienced hypotension, the number of these patients was not identified but they were the patients who were also on beta blockers or calcium channel blockers preoperatively. </p> <p>In <a href="./references#CD004087-bbs2-0002" title="AliAR , ElGoharyM , AshmawiHSE , El‐KerdawyHM , EssaHH . Efficacy of preoperative gabapentin in attenuation of neuroendocrine response to laryngoscopy and endotracheal intubation. Journal of Medical Science2009;9:24‐9. ">Ali 2009</a>, one patient who received gabapentin 800 mg orally had a transient decrease in systolic arterial pressure (<a href="./references#CD004087-fig-0013" title="">Analysis 3.5</a>). </p> <p>A summary of these results on side effects is presented in <a href="./appendices#CD004087-sec-0130">Appendix 8</a>. </p> </section> <section id="CD004087-sec-0108"> <h5 class="title">Route of administration and morbidity</h5> <p>The intravenous route was used in 48 trials. Lignocaine and nitroglycerine were the two drugs where a variety of routes were used. As the dosage of these drugs was not the same in the different trials, we did not perform any further analysis based on route as no meaningful conclusion could be drawn. </p> </section> <section id="CD004087-sec-0109"> <h5 class="title">High risk patient studies</h5> <p>Seventeen trials were conducted in high risk patients. Different drugs and different dosages were used. </p> <p>Twelve studies investigated patients with coronary artery disease. The following drugs were tested: lignocaine spray via the tracheal route (<a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>), IV lignocaine (<a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>), sublingual nifedipine (<a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>), topical nitroglycerine (<a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>), IV nitroglycerine (<a href="./references#CD004087-bbs2-0021" title="HartAP , CamporesiEM , SellTL , CroughwellN , SilvaR , JonesRH , et al. The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography. Anesthesia and Analgesia1989;68:718‐23. [PUBMED: 2500040] ">Hart 1989</a>; <a href="./references#CD004087-bbs2-0068" title="ThomsonIR , MutchWA , CulliganJD . Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischaemia during fentanyl‐pancuronium anesthesia. Anesthesiology1984;61:385‐93. [PUBMED: 6435481] ">Thomson 1984</a>), IV esmolol (<a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0053" title="NewsomeLR , RothJV , HugCCJr , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65:451‐6. [PUBMED: 3485937] ">Newsome 1986</a>), IV labetalol (<a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>), magnesium sulphate (<a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>), and IV fentanyl (<a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a>). <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a> investigated the effects of esmolol and fentanyl in ASA 3 and 4 patients. This was a mixed group with hypertension and Ischaemic heart disease. </p> <p>Two studies investigated hypertensive patients (<a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) and looked at the effects of metoprolol, labetalol, atenolol, and oxprenolol. <a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a> included neurosurgical patients in the trial and looked at the effects of IV fentanyl. <a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a> recruited patients undergoing intracranial surgery. <a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a> studied the effects of IV esmolol in patients undergoing carotid endarterectomy. </p> <p>Four studies observed participants only for arrhythmias (<a href="./references#CD004087-bbs2-0014" title="DahlgrenN , MesseterK . Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia1981;36:1022‐6. [PUBMED: 7032347] ">Dahlgren 1981</a>; <a href="./references#CD004087-bbs2-0017" title="DenlingerJK , EllisonN , OminskyAJ . Effects of intratracheal lidocaine on circulatory responses to tracheal intubation. Anesthesiology1974;41:409‐12. [PUBMED: 4413148] ">Denlinger 1974</a>; <a href="./references#CD004087-bbs2-0022" title="InadaE , CullenDJ , NemeskalAR , TeplickR . Effect of labetalol or lidocaine on the hemodynamic response to intubation: A controlled randomized double‐blind study. Journal of Clinical Anesthesia1989;1:207‐13. [PUBMED: 2697239] ">Inada 1989</a>; <a href="./references#CD004087-bbs2-0023" title="IyerV , RussellWJ . Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?. Anaesthesia and Intensive Care1988;16:411‐7. [PUBMED: 3232799] ">Iyer 1988</a>), eight observed participants only for ischaemia (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0016" title="DeBrujinNP , CroughwellN , RevesJG . Hemodynamic effects of esmolol in chronically beat‐blocked patients undergoing aortocoronary bypass surgery. Anesthesia and Analgesia1987;66:137‐41. [PUBMED: 2880530] ">De Brujin 1987</a>; <a href="./references#CD004087-bbs2-0019" title="EbertJP , PearsonJD , GelmanS , HarrisC , BradleyEL . Circulatory responses to laryngoscopy: the comparative effect of placebo, fentanyl and esmolol. Canadian Journal of Anesthesia1989;36:301‐6. [PUBMED: 2566391] ">Ebert 1989</a>; <a href="./references#CD004087-bbs2-0020" title="GirardD , ShulmanBJ , ThysDM , MindichBP , MikulaSK , KaplanJA . The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology1986;65:157‐64. [PUBMED: 3526984] ">Girard 1986</a>; <a href="./references#CD004087-bbs2-0021" title="HartAP , CamporesiEM , SellTL , CroughwellN , SilvaR , JonesRH , et al. The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography. Anesthesia and Analgesia1989;68:718‐23. [PUBMED: 2500040] ">Hart 1989</a>; <a href="./references#CD004087-bbs2-0053" title="NewsomeLR , RothJV , HugCCJr , NagleD . Esmolol attenuates hemodynamic responses during fentanyl‐pancuronium anesthesia for aortocoronary bypass surgery. Anesthesia and Analgesia1986;65:451‐6. [PUBMED: 3485937] ">Newsome 1986</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>; <a href="./references#CD004087-bbs2-0068" title="ThomsonIR , MutchWA , CulliganJD . Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischaemia during fentanyl‐pancuronium anesthesia. Anesthesiology1984;61:385‐93. [PUBMED: 6435481] ">Thomson 1984</a>), and five observed participants for both (<a href="./references#CD004087-bbs2-0013" title="CucchiaraRF , BenefielDJ , MatteoRS , DeWoodM , AlbinS . Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology1986;65:528‐31. [PUBMED: 2877599] ">Cucchiara 1986</a>; <a href="./references#CD004087-bbs2-0025" title="KaleSC , MahajanRP , JayalakshamiTS , RaghavanV , DasB . Nifedipine prevents the pressor response to laryngoscopy and tracheal intubation in patients with coronary artery disease. Anaesthesia1988;43:495‐7. [PUBMED: 3261548] ">Kale 1988</a>; <a href="./references#CD004087-bbs2-0037" title="MagnussonJ , ThulinT , WernerO , JarhultJ , ThomsonD . Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. British Journal of Anaesthesia1986;58:251‐60. [PUBMED: 3511930] ">Magnusson 1986</a>; <a href="./references#CD004087-bbs2-0038" title="MahajanRP , RamachandranR , SaxenaN . Topical nitroglycerin prevents the pressor response to tracheal intubation and sternotomy in patients undergoing coronary artery bypass graft surgery. Anaesthesia1993;48:297‐300. [PUBMED: 8494129] ">Mahajan 1993</a>; <a href="./references#CD004087-bbs2-0057" title="PuriGD , MarudhachalamKS , ChariP , SuriRK . The effect of magnesium sulphate on haemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesthesia and Analgesia1998;87:808‐11. [PUBMED: 9768774] ">Puri 1998</a>). </p> <p>The details of the results of these studies have been summarized in <a href="./appendices#CD004087-sec-0131">Appendix 9</a> and <a href="./appendices#CD004087-sec-0132">Appendix 10</a>. The analysis of studies with high risk patients has been presented in the text. Data from two studies has not been included in the appendices (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) but have been discussed in the text. </p> </section> <section id="CD004087-sec-0110"> <h5 class="title">Pharmacological agents where only a single study was available</h5> <p><a href="./appendices#CD004087-sec-0127">Appendix 5</a> lists the summary of results where only a single study was available for a particular drug. In addition, single studies were available for hydralazine (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>), atenolol, and oxprenolol (<a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>) but they have not been included in the Appendix. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004087-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004087-sec-0111"></div> <p>This review concerns the randomized evidence for the use of pharmacological agents to modify the haemodynamic response to laryngoscopy and tracheal intubation. Specifically, we have collated the data on the clinically relevant outcomes of morbidity and mortality (primary outcomes) and the surrogate measures (secondary outcomes) arrhythmia and ECG evidence of myocardial ischaemia. </p> <section id="CD004087-sec-0112"> <h3 class="title" id="CD004087-sec-0112">Summary of main results</h3> <p>Only two studies reported each of our primary outcomes of mortality and morbidity (<a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>; <a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>). Neither of these outcomes was reported in any arm of any other study, suggesting that these clinical outcomes are probably rare (as we anticipated). </p> <p>To find out the risk of arrhythmias and myocardial ischaemia, we reviewed 72 studies involving eight different pharmacological groups (local anaesthetics, calcium channel blockers, sympathetic blockers, peripheral vasodilators, centrally acting alpha agonists, narcotics, ACE inhibitors, and a group of miscellaneous drugs). We found data on a total of 32 different drugs.Data from four trials was not included in the analysis. In total, 60 studies reported arrhythmias and 31 reported the ECG changes of myocardial ischaemia as an outcome measure. Our systematic review suggests that the pre‐anaesthetic administration of local anaesthetics, calcium channel blockers, beta blockers, or narcotics is associated with a significant decrease in the risk of arrhythmias associated with laryngoscopy and intubation when compared to placebo. Arrhythmias were observed in 134 out of 993 patients in the control group compared to 80 out of 1939 in the intervention group (P &lt; 0.00001). </p> <p>In total, 31 studies included myocardial ischaemia as an outcome. None of the studies examined the association of intraoperative ECG changes to any clinical outcome such as postoperative myocardial infarction or postoperative persistent changes in ECG. Overall, the use of pharmacological agents resulted in a significant reduction in the risk of ischaemic episodes. Myocardial ischaemia was observed in 21 out of 604 patients in the control group compared to 10 out of 1012 in the treatment group with a statistically significant result (P = 0.01). This result should be treated with caution, however, because in 20 of the included studies no patient in either the control or interventional group suffered this outcome and thus only nine studies contributed to the analysis. Further, the local anaesthetic group was the only subgroup analysis that indicated a significant difference with pretreatment, and that analysis was dominated by a single study (<a href="./references#CD004087-bbs2-0005" title="AsfarSN , AbdullaWY . The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation. Acta Anaesthesiologica Belgica1990;41:17‐24. [PUBMED: 2360387] ">Asfar 1990</a>). The largest subgroup contributing to this data was studies with beta blockers (five studies with positive outcomes) and pretreatment did not show a statistically significant difference compared to placebo. These results could be explained on the basis that myocardial ischaemia was a relatively rare event and the studies were underpowered to look at this complication. Larger datasets may be required to reach meaningful conclusions. </p> <p>In the subgroup analysis comparing the effects of pharmacological agents on the risk of myocardial ischaemia in high risk patients versus low risk patients, treatment was effective in low risk patients but no effect was observed in high risk patients. This could again be due to the rarity of the events or due to the fact that patients may have been on other medications that may influence the outcome. More studies are needed in the high risk population. </p> </section> <section id="CD004087-sec-0113"> <h3 class="title" id="CD004087-sec-0113">Overall completeness and applicability of evidence</h3> <p>The majority of studies (70%) in our review were conducted in relatively healthy ASA 1 and 2 patients, and therefore there are limitations in extrapolating these results to high risk, vulnerable patients. There were only two studies (<a href="./references#CD004087-bbs2-0050" title="MikawaK , NishinaK , MaekawaN , ObaraH . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. British Journal of Anaesthesia1996;76:221‐6. [PUBMED: 8777101] ">Mikawa 1996</a>; <a href="./references#CD004087-bbs2-0051" title="MillerDR , MartineauRJ , HullKA , HillJ . Bolus administration of esmolol for controlling the hemodynamic response to laryngoscopy and intubation: The Canadian multicentre trial. Canadian Journal of Anaesthesia1991;38:849‐58. [PMID 1683818] ">Miller 1991</a>) that reported our primary outcome but provided no details. Most of the remaining studies were primarily designed to observe the blood pressure and heart rate changes, and only nine studies addressed the consequence of these changes as part of their objectives or methodology (<a href="./references#CD004087-bbs2-0021" title="HartAP , CamporesiEM , SellTL , CroughwellN , SilvaR , JonesRH , et al. The effect of nitroglycerin on response to tracheal intubation. Assessment by radionuclide angiography. Anesthesia and Analgesia1989;68:718‐23. [PUBMED: 2500040] ">Hart 1989</a>; <a href="./references#CD004087-bbs2-0029" title="KoS , KimD , HanY , SongH . Small‐does fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesthesia and Analgesia1998;86:658‐61. [PUBMED: 9495433] ">Ko 1998</a>; <a href="./references#CD004087-bbs2-0033" title="LeeSH , LeeCJ , KimTH , ShinBS , LeeSY , JooEY , et al. Novel use of hydromorphone as a pretreatment agent: a double‐blind, randomized, controlled study in adult Korean surgical patients. Current Therapeutic Research2011;72:36‐48. ">Lee 2011</a>; <a href="./references#CD004087-bbs2-0034" title="LindgrenL , SarnivaraL , KlemolaUM . Protection by fentanyl against cardiac dysrhythmias during induction of anaesthesia. European Journal of Anaesthesiology1987;4:229‐33. [PUBMED: 3653018] ">Lindgren 1987</a>; <a href="./references#CD004087-bbs2-0040" title="MallonJS , HewE , WaldR , KapalaD . Bolus doses of esmolol for the prevention of postintubation hypertension and tachycardia. Journal of Cardiothoracic Anesthesia1990;4:27‐30. ">Mallon 1990</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>; <a href="./references#CD004087-bbs2-0067" title="SunHL , WuTJ , NgCC , ChienCC , HuangCC , ChieWC . Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. Journal of Clinical Anesthesia2009;21:103‐7. [PUBMED: 19329013] ">Sun 2009</a>; <a href="./references#CD004087-bbs2-0068" title="ThomsonIR , MutchWA , CulliganJD . Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischaemia during fentanyl‐pancuronium anesthesia. Anesthesiology1984;61:385‐93. [PUBMED: 6435481] ">Thomson 1984</a>; <a href="./references#CD004087-bbs2-0070" title="WangYM , ChungKC , LuHF , HuangYW , LinKC , YangLC , et al. Lidocaine: the optimal timing of intravenous administration in attenuation of increase of intraocular pressure during tracheal intubation. Acta Anaesthesiologica Sinica2003;41:71‐5. [PUBMED: 12934420] ">Wang 2003</a>). We were unable to usefully compare the effectiveness of individual drugs within each pharmacological class because of the variation in dose, timing, and route of administration. This review nevertheless suggests that even these low risk patients are susceptible to cardiac arrhythmia and ECG evidence of myocardial ischaemia as a consequence of haemodynamic changes related to tracheal intubation. Of these low risk patients, 13% had arrhythmias and 1.4 % had myocardial ischaemia when a placebo was given prior to laryngoscopy and intubation. Pre‐induction use of pharmacological agents reduced this risk to 4.5% for arrhythmias and nil for myocardial ischaemia. </p> <p>In clinical practice, the use of agents to reduce the response to laryngoscopy and intubation is likely to be of most importance in those patients at high risk of morbidity due to concurrent cardiovascular disease. In this review, 17 (23%) of the studies were conducted in high risk patients; two enrolled hypertensive patients, 12 enrolled patients with coronary artery disease, two enrolled neurosurgical patients, and one enrolled patients with carotid artery disease. Data from two of these studies were not subjected to analysis (<a href="./references#CD004087-bbs2-0015" title="DaviesMJ , CroninKD , CowieRW . The prevention of hypertension at intubation. A controlled study of intravenous hydralazine on patients undergoing intracranial surgery. Anaesthesia1981;36:147‐52. [PUBMED: 7011085] ">Davies 1981</a>; <a href="./references#CD004087-bbs2-0066" title="StoneJG , FoexP , SearJW , JohnsonLL , KhambattaHJ , TrinerL . Myocardial ischemia in untreated hypertensive patients: effect of a single dose of a beta adrenergic blocking agent. Anesthesiology1988;68:495‐500. [PUBMED: 2895596] ">Stone 1988</a>). It is in this vulnerable population of patients where it is most important to attenuate the haemodynamic response related to tracheal intubation in order to avoid important morbidity. When the high risk studies were pooled (15 studies), pharmacological treatment resulted in a reduction in the risk of arrhythmias but not in ECG evidence of ischaemia. It is difficult to comment on the negative results as, despite pooling these studies, our analysis may still be underpowered to reliably quantify any protective effect. There was also considerable heterogeneity with varying doses of individual agents used in these studies, therefore a particular dose of any agent cannot be recommended. </p> <p>All the studies in our review only mentioned the nature and the risk of arrhythmia but did not comment on the percentage of participants requiring treatment or any further morbidity related to the rhythm disturbance. Patient anxiety was not taken into consideration and indeed, the premedication given to the participants was variable and may have influenced the outcome in some trials. </p> <p>Different ECG leads were used for detection of myocardial ischaemia. Some studies used lead 2 for intraoperative ECG monitoring, whereas others did not mention the lead used. Lead 2 is not the best lead to be used for intraoperative ECG monitoring of ischaemia. </p> <p>Substantial heterogeneity was seen in the results with two of the groups that is local anaesthetics (I² = 79%) and narcotics (I² = 58%) suggesting that drug effect may not be uniform across these groups. On the other hand, the calcium channel blocker group and beta blocker group were fairly homogenous across the studies indicating that different drugs within these classes may exhibit a similar magnitude of effect. </p> <p>Pharmacological treatment was seen to be effective in both high risk and low risk patients, but substantial heterogeneity was seen in the studies of high risk patients for arrhythmia (I<sup>2</sup> = 80%). </p> <p>Despite this clinical heterogeneity, the studies did show a benefit over placebo with some pharmacological agents in decreasing the risk of arrhythmia and future research should concentrate on further evaluation of these drugs. </p> <p>The above limitations should be kept in mind when applying this evidence in everyday practice </p> </section> <section id="CD004087-sec-0114"> <h3 class="title" id="CD004087-sec-0114">Quality of the evidence</h3> <p>While we only included randomized studies in this review, many of them (particularly those done before year 2000) did not report details of randomization and treatment allocation. We included both blinded and non‐blinded studies. Many of the blinded studies did not report the details of the blinding process. Therefore, in general, the methodological quality of the majority of the included studies was poor (<a href="#CD004087-fig-0002">Figure 2</a>). </p> <p>There were many other sources of heterogeneity present in this review. In total, 27 studies used only a small sample size of 10 or fewer participants in one of the study arms. This is likely to result in a lot of random variation. A sample size calculation was again not mentioned in the majority of studies. </p> <p>Different routes and dosages were used in the same pharmacological group or for the same drug in the different studies. There were also variations in the use of induction agents and the muscle relaxant used for tracheal intubation. The timing of the administration of the same drugs in relation to induction was different in different studies. Factors like duration of laryngoscopy were controlled in some studies but not in all. This type of heterogeneity made it difficult to compare different trials of even the same drug. Because of this heterogeneity we were unable to get an answer to our third review question that is whether the route of administration of the agents was associated with a significant difference in respect of the studied outcomes. </p> </section> <section id="CD004087-sec-0115"> <h3 class="title" id="CD004087-sec-0115">Potential biases in the review process</h3> <p>We attempted to minimize bias by following the guidelines recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>.The eligibility for inclusion and exclusion and assessment of risk of bias of the different studies was carried out independently by two authors. </p> </section> <section id="CD004087-sec-0116"> <h3 class="title" id="CD004087-sec-0116">Agreements and disagreements with other studies or reviews</h3> <p>We are unaware of other systematic reviews specifically addressing the complications related to the haemodynamic response to laryngoscopy and tracheal intubation. Two systematic reviews addressed the efficacy of esmolol (<a href="./references#CD004087-bbs2-0104" title="FigueredoE , Garcia‐FuentesEM . Assessment of the efficacy of esmolol on the hemodynamic changes induced by laryngoscopy and tracheal intubation: a meta‐analysis. Acta Anaesthesiologica Scandinavica2001;45:1011‐22. [PUBMED: 11576054] ">Figueredo 2001</a>) and landilol ( <a href="./references#CD004087-bbs2-0107" title="IonueS , TanakaY , KawaguchiM , FuruyaH . The efficacy of landilol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review. Anaesthesia and Intensive Care2009;37:893‐902. [PUBMED: 20014594] ">Ionue 2009</a>) on the haemodynamic changes following laryngoscopy and tracheal intubation but they did not include myocardial ischaemia or arrhythmia as an outcome. Another narrative review (<a href="./references#CD004087-bbs2-0109" title="KovacLA . Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. Journal of Clinical Anaesthesia1996;8:63‐79. [PUBMED: 8695083] ">Kovac 1996</a>) reviewed the common causes and treatment of hypertension and tachycardia during laryngoscopy and tracheal intubation but did not include myocardial ischaemia or arrhythmia as an outcome. A French narrative review (<a href="./references#CD004087-bbs2-0101" title="BruderN , OrtegaD , GranthillC . Consequences and prevention methods of hemodynamic changes during laryngoscopy and intratracheal intubation. Annales Françaises d'Anesthésie et de Réanimation1992;11:57‐71. [PUBMED: 135981] ">Bruder 1992</a>) looked at the consequences and prevention methods of haemodynamic changes during laryngoscopy and intratracheal intubation. We are awaiting translation of this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004087-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD004087-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004087-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004087-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Arrhythmias, Outcome 1 Arrhythmias ‐ by drug type." data-id="CD004087-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Arrhythmias, Outcome 1 Arrhythmias ‐ by drug type.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Arrhythmias, Outcome 2 Arrhythmias ‐ sympathetic blockers." data-id="CD004087-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Arrhythmias, Outcome 2 Arrhythmias ‐ sympathetic blockers.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Arrhythmias, Outcome 3 Arrhythmias ‐ high risk vs low risk patients." data-id="CD004087-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Arrhythmias, Outcome 3 Arrhythmias ‐ high risk vs low risk patients.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ECG evidence of myocardial ischaemia, Outcome 1 Myocardial ischaemia ‐ by drug type." data-id="CD004087-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 ECG evidence of myocardial ischaemia, Outcome 1 Myocardial ischaemia ‐ by drug type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 ECG evidence of myocardial ischaemia, Outcome 2 Myocardial ischaemia ‐ high risk vs low risk patients." data-id="CD004087-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 ECG evidence of myocardial ischaemia, Outcome 2 Myocardial ischaemia ‐ high risk vs low risk patients. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adverse effects, Outcome 1 Local anaesthetics." data-id="CD004087-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Adverse effects, Outcome 1 Local anaesthetics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adverse effects, Outcome 2 Beta blockers." data-id="CD004087-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Adverse effects, Outcome 2 Beta blockers.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adverse effects, Outcome 3 Combined alpha and beta blockers." data-id="CD004087-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Adverse effects, Outcome 3 Combined alpha and beta blockers.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adverse effects, Outcome 4 Narcotics." data-id="CD004087-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Adverse effects, Outcome 4 Narcotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004087-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/urn:x-wiley:14651858:media:CD004087:CD004087-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_t/tCD004087-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adverse effects, Outcome 5 Miscellaneous." data-id="CD004087-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Adverse effects, Outcome 5 Miscellaneous.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/media/CDSR/CD004087/image_n/nCD004087-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004087-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Pharmacological agents compared with placebo or no treatment for attenuating the haemodynamic response to tracheal intubation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: Adult patients 18 years and above undergoing elective surgery</b> </p> <p><b>Settings: Operating room</b> </p> <p><b>Intervention: Pharmacological agents given for the specific purpose of attenuating the haemodynamic response to tracheal intubation</b> </p> <p><b>Comparison: Control group receiving placebo or no treatment</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Pharmacological agents</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Arrhythmias ‐ by drug type in all patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.19</b> </p> <p>(<b>0.14 to 0.27</b>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>2902</b> <br/> <b>(57)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>·  .</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> <br/> <b>(21 to 40)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Arrhythmias ‐ high risk patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.18</b> </p> <p><b>(0.05 to 0.59)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>337</b> <br/> <b>(9)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>· </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> <b>(4 to 49)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Myocardial Ischaemia ‐ by drug type in all patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>0.36</b> </p> <p><b>(0.16 to 0.8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>1636</b> <br/> <b>(30)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>· </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>13 per 1000</b> </p> <p><b>(6 to 28)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial Ischaemia ‐ high risk patients</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>0.67</b> </p> <p><b>(0.27 to 1.67)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>395</b> <br/> <b>(12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>·  </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>78 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>53 per 1000</b> </p> <p><b>(22 to 123)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; [other abbreviations, e.g.. OR, etc] </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>43 of the studies were blinded.All studies mentioned randomization but details were only provided by eight; 13 studies described allocation concealment </p> <p><sup>2</sup>Six studies out of nine with high risk patients were blinded </p> <p><sup>3</sup>Eight studies were blinded.In nine studies details of randomization were mentioned; 12 had allocation concealment and five studies had withdrawals </p> <p><sup>4</sup>Six studies out of 12 with high risk patients were blinded </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/full#CD004087-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004087-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Arrhythmias</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Arrhythmias ‐ by drug type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.14, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Local anaesthetics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Calcium channel blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.04, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Sympathetic blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.12, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Centrally acting alpha agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 3.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Peripheral vasodilators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Narcotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.07, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Miscellaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Arrhythmias ‐ sympathetic blockers <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.12, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Beta blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>589</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.12, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Combined alpha and beta blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Alpha blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Arrhythmias ‐ high risk vs low risk patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.14, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High risk patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.05, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low risk patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2529</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.14, 0.28]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Arrhythmias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004087-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ECG evidence of myocardial ischaemia</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Myocardial ischaemia ‐ by drug type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Local anaesthetics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Calcium channel blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Sympathetic blockers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.25, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Peripheral vasodilators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.26, 8.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Centrally acting alpha agonists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Narcotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 8.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Miscellaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.00, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Myocardial ischaemia ‐ high risk vs low risk patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.16, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High risk patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.27, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low risk patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.01, 0.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ECG evidence of myocardial ischaemia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004087-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adverse effects</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Local anaesthetics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.27 [4.03, 37.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Beta blockers <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>24.17 [8.88, 65.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Combined alpha and beta blockers <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.43 [0.81, 50.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Narcotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>149.55 [35.07, 637.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Miscellaneous <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.46 [0.99, 56.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adverse effects</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004087.pub2/references#CD004087-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004087.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004087-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004087-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="pt#CD004087-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004087\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004087\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004087\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004087\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004087\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=u3GUW7vS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004087.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004087.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004087.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004087.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004087.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716694651"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004087.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716694654"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004087.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da5c1bc729368',t:'MTc0MDcxNjY5NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 